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New Approaches towards the Asymmetric Allylation of the Formyl  and Imino Groups via 
Strained Silane Lewis Acids 
Alexander Buitrago Santanilla 
This dissertation presents new approaches towards the asymmetric allylation of the imino 
and formyl functionalities by using strained silanes as Lewis acids. Here in the Laboratory 
of Professor James L. Leighton, chiral homoallylic alcohols and amines are considered 
privileged products given their important role as building blocks in natural product 
synthesis. The new approaches reported herein are focused on expanding the scope of imine 
allylation reactions and gaining full synthetic utility of the corresponding homoallylic 
amine products by means of economic and user-friendly protocols. In addition, the 
discovery of a novel catalytic and mild approach to the asymmetric allylation of aldehydes 
will be the focus of discussion at the end of this works. Chapter 1 will give a brief 
introduction about general concepts in asymmetric allylation of aldehydes and imines as 
well as in applications of strained silane Lewis acids in these reactions. Chapter 2 will 
discuss the development of a novel asymmetric allylation method for N-heteroaryl 
hydrazones and the N-heteroaryl cleavage from the product to unmask the corresponding 
free amines. Chapter 3 will carry on these studies into different imine activating groups in 
search for a more general and user-friendly approach towards both allylation and cleavage 
protocols. Finally, Chapter 3 will discuss the development of a new methodology in which 
chiral bismuth (III) complexes can catalyze the asymmetric allylation of aldehydes with 
achiral strained allylsilanes.  
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Strained Silanes in the Allylation of the Carbonyl and Imino Groups 
1.1. Introduction 
It is an unquestionable reality that the literature is flooded with the concept of 
asymmetric allylation. A simple Scifinder® search for those two simple words yields 1,920 
references, which comes as no surprise since the corresponding homoallylic alcohols or 
amines derived from asymmetric allylation are perhaps among the most valuable and 
versatile chiral building blocks in natural product synthesis
1
. Throughout the years, several 
stoichiometric and catalytic approaches to access these types of products have demonstrated 
high levels of creativity from the researchers involved in their development
2
. One of the 
most exploited approaches to these products is the asymmetric metal-allyl fragment 
addition to aldehydes and imines, which many researchers have studied in great detail in 
terms of substrate and reagent control. 
The asymmetric addition of metal-allyl fragments to carbonyl and imino groups has 
been mechanistically categorized in three major types:
3
 Type I, II, and III (Scheme 1-1). We 
will use aldehydes for simplicity to portray examples of those categories. Type I allylation 
invokes a closed chair-like six-membered transition state, in which the metal or metalloid 
serves a dual function: acting as a Lewis acid to activate the aldehyde and transferring the 
allyl fragment. This highly organized transition state renders the allyl transfer 
diastereospecific, in which the (E)-allyl fragment gives the anti-product, and the (Z)-allyl 





allyl fragments, in which the metal is not Lewis acidic. Thus, an external Lewis acid is 
required to activate the aldehyde as well as a promoting nucleophile to attack the silicon. 
The major consequence of this requirement is that the reaction proceeds via an open 
transition state, in which the syn-product is the most favorable outcome as it bypasses more 
severe gauche interactions in the transition state. Finally, Type III allylation invokes the use 
of a Lewis acidic metal-allyl fragment in rapid isomerization to the E isomer regardless of 
the initial E/Z content. The reaction occurs via a closed transition state like in Type I, 
resulting in the anti-diastereomer as the major product. 








1.1.1. Asymmetric Allylation of Aldehydes 
From the scheme above, it becomes clear that there are several advantages and 
limitations within each allylation type. For instance, in Type I, while one can access each 
product diastereomer, it is required to separately synthesize the (E) and (Z) reagents which 
can turn out to be cumbersome in certain cases. A relevant example to this type of allylation 
is the Brown crotylation
4
 of aldehydes, in which high levels of enantio and 
diastereoselectivity are achieved at the expense of inconvenient reaction conditions such as 
rigorous timing and cryogenic monitoring for high selectivity and byproduct separation 
(Scheme 1-2).  
Scheme 1-2: Brown Crotylation of Aldehydes 
 
In Type II allylation, a clear disadvantage is that one can only or most exclusively 
access the syn-product. An example of Type II allylation is that of Kumada and coworkers
5
 
in which optically active trimethylsilanes are added to aldehydes in the presence of titanium 





Scheme 1-3: Addition of Chiral Crotyltrimethylsilanes to Aldehydes 
 
 Similarly, in Type III allylations one can only or almost exclusively access the anti-
product. A relevant example of Type III allylation is the addition of chiral crotyltitanium 
reagents to aldehydes developed by Hafner and coworkers
6
 (Scheme 1-4). The 
crotyltitanium reagent is obtained from the corresponding chlorotitanium precursor and (E)-
crotylmagnesium chloride or (Z)-crotylpotassium. However, fast isomerization to the (E)-
crotyltitanium reagent accounts for the high stereospecificity for the anti-product given that 
the reaction goes through a closed transition state.  
Scheme 1-4: Addition of Chiral Crotyltitanium Reagents to Aldehydes 
 
 While all of the examples discussed so far correspond to stoichiometric methods, 







very major discovery of this type and relevant to the contents of this thesis was that of 
Denmark and coworkers
8
. In this method, an achiral (E) or (Z) crotyltrichlorosilane 
activated by complexation with catalytic amounts of a chiral bisphosphoramide can 
asymmetrically crotylate aldehydes, albeit only aromatic, via the Type I mechanism in good 
yields and enantioselectivities and excellent diastereoselectivities (Scheme 1-5). 
Scheme 1-5: Denmark Catalytic Crotylation of Aldehydes 
 
1.1.2. Asymmetric Allylation of Imines 
Besides aldehyde allylation, which was exemplified in all cases above, imines may 
also undergo allylation reactions of the same types. However, approaches to imine 
allylation are more diverse and complex since there is plenty of exploratory room to control 
reactivity and selectivity from the substrate itself by means of chiral auxiliaries or activators 
on the imine nitrogen or by means of chiral reagents
9
. Also, new challenges arise since not 
all imines are configurationally stable and may undergo E/Z isomerization and/or 





Figure 1-1: Challenges in Asymmetric Imine Allylation 
 
In fact, structural features of the imine itself redefine the outcome of products in 
Type I allylation. For instance, the lone pair trans to the R
1
 group in an aldehyde does not 
exist in a typical (E)-imine as this position is substituted with another group R
2
 (Figure 1-2). 
Thus, in order to involve the imine nitrogen lone pair in the closed transition state, the R
1 
group will now occupy the pseuodoaxial position of the chair unless there are other 
conformers involved, such as a boat, or in situ-bound imine isomerization to the (Z) 
geometry.   
Figure 1-2: Type I Allylation in Imines 
 
Asymmetric addition of an unsubstituted allyl group to an imine has been greatly 
exploited
10
. However, when it comes to addition of more complex allyl fragments to imines 





issue is the synthesis of the required complex allyl fragments and their incorporation as part 
of the allyl transfer reagent. Similarly, the design, installation, and cleavage of an activating 
group on the imine nitrogen can be a complex if not cumbersome task, which can in the end 
render methods highly substrate dependent and/or disabling the relevant synthetic utility of 
the resulting allylation products (Figure 1-3). 
Figure 1-3: Additional Challenges in Imine Asymmetric Allylation 
 
 Indeed, there are only a few examples in the literature in which complex allyl 
fragments such as cinnamyl groups are added to imines with high enantio and 
diastereoselectivity
11
. The first example of truly asymmetric cinnamylation of imines was 
that of Sato and coworkers
12
 in which a chiral N-(α-methylbenzyl)-derived imine 3 is 
subjected to an in situ generated cinnamyltitanium reagent to give the corresponding syn-










Scheme 1-6: First Asymmetric Cinnamylation of Imines 
 
Another variant of this reaction is the addition cinnamylzinc bromide to chiral glyoxamide-
derived imine 5 by Hanessian and coworkers
13
 to obtain the corresponding cinnamylation 
product in good yield and excellent diastereoselectivity (Scheme 1-7). 
 
Scheme 1-7: Asymmetric Glyoxamide-derived Imine Cinnamylation 
 
 Almost a decade later from the method above, Lee and coworkers
14
 reported the use 
of phenylglycinamide-derived imines in the asymmetric addition of cinnamylzinc bromide, 








Scheme 1-8: Asymmetric Glycinamide-derived Imine Cinnamylation 
 
 More recently, Reddy and coworkers
15
 have reported the cinnamylation of chiral N-
tert-butanesulfinylimines with cinnamylzinc reagents, being able to obtain the syn 
cinnamylation products in high yields and excellent diastereoselectivities (Scheme 1-9).  
Scheme 1-9: Cinnamylation of Chiral N-tert-butanesulfinylimines 
 
The methodologies presented above are highly substrate controlled as the activating 
group and chirality source have been designed to be part of the imine substrate. With the 
exception of the last example presented, those activating groups are not readily installed or 







, in which a cinnamylzinc reagent complexed by chiral BOX 
ligands is able to cinnamylate cyclic imines in great yields, modest enantioselectivity, and 
excellent diastereoselectivity (Scheme 1-10).  
Scheme 1-10: Asymmetric Cinnamylation of Cyclic Imines 
 
A noteworthy observation from the methods presented above is the almost exclusive 
access to one diastereomer, predominantly the syn-product. This can be attributed to the 
Type III nature of the cinnamyl-metal species, which seems to be rapidly isomerizing to the 
(E)-isomer regardless of the initial E/Z content, then reacting with the imine in a closed 
transition state to provide the observed syn product
17
. 
There have also been advances in the field of asymmetric catalysis for the allylation 
of imines
18
. Some of which have extended to the addition of more complex allyl fragments. 
One relevant and seminal example of such additions to imines is the asymmetric crotylation 
of N-acylhydrazones using crotyltrichlorosilanes with a chiral sulfoxide as the catalyst as 
reported by Kobayashi and coworkers
19
 (Scheme 1-11). In this case, the chiral sulfoxide 
serves as a Lewis base to activate the crotyltrichlorosilane. The reaction proceeds via a 
Type I mechanism, with moderate to excellent yields and good to excellent enantio and 





cryogenic conditions. This method resembles much of the work of Denmark and coworkers 
presented earlier in the chapter on the catalytic crotylation of aldehydes using 
crotyltrichlorosilanes with chiral bisphosphoramides as catalysts.  
Scheme 1-11: Chiral Sulfoxide Catalyzed Asymmetric Crotylation of Acylhydrazones 
 
 Another more recent and relevant method has been reported by Schaus and 
coworkers
20
, in which N-benzoyl imines are asymmetrically crotylated using crotyl 
isopropyl boronates with chiral binaphthol as a catalyst (Scheme 1-12). This method has 
proven to be very broad in substrate scope for simple allylation reactions and very practical 
in experimental setup, but it suffers a major limitation in crotylation reactions as both the 








Scheme 1-12: Chiral Binaphthol Catalyzed Crotylation of N-benzoyl Imines 
 
  The representative examples for asymmetric aldehyde and imine allylation we 
provided above are among the best methods within that field
21
. One can then appreciate that 
there is much more work left to do in order to approach a more general and ideal 
asymmetric allylation protocol that allows for both simple and complex allyl transfer 
reactions to a broad scope of substrates, utilizing user-friendly conditions, and economic 
reagents. In the imine case, the activating group design is the most important consideration 
after the allyl transfer reaction itself as it determines the real synthetic utility of the 
homoallylic amine products.  
 With the picture of an ideal asymmetric allylation reaction in mind, the Leighton 
group here at Columbia University has been making progress in getting closer to that 
depiction. In particular, this has been by means of exploiting the idea of silicon strained-
release Lewis acidity
22
, which potential was overlooked in the previous years since its 
discovery. In synthetic organic chemistry, silicon is most widely seen in the realm of 





concept and used it in the development of several asymmetric allylation protocols, some of 
which will be discussed in the rest of this chapter.  
 
1.2. Strained Allylsilicon Reagents 
Allylsilicon reagents have been mostly known in the Hosomi-Sakurai-like reactions
23
, 
in which a nucleophilic allylsilane adds to an exogenous Lewis acid-activated aldehyde 
(Scheme 1-13). These reactions commonly undergo Type II mechanisms, proceeding via an 
open transition state. The role of silicon in these reactions is to stabilize the buildup of 
positive charge at the β-carbon to it as the terminal olefin attacks the activated carbonyl. 
This stabilization is also known as the β-silicon effect24. A typical example of this kind of 
reaction was presented in section 1.1.1 where type II allylations were discussed. 
Figure 1-4: The Hosomi-Sakurai Reaction 
 
 More than a decade after the discovery of the Hosomi-Sakurai reaction, Utimoto and 
coworkers
25
 reported that allylsilacyclobutane 1.1 reacts with benzaldehyde to give the 
corresponding homoallylic product in 85% yield (Scheme 1-13). This was very 
groundbreaking at the time as trialkylsilanes typically require an exogenous Lewis acid-
activated aldehyde for allyl transfer in a Type II fashion. In fact, allyldimethylphenylsilane 







Scheme 1-13: Allylsilacyclobutane Allylation of Benzaldehyde 
 
 Interestingly, (E) and (Z) n-propyl analogues of silane 1.1 reacted with 
benzaldehyde to give highly diastereoselective anti and syn products, respectively (Scheme 
1-14).  
Scheme 1-14: Crotylsilacyclobutane Reactions with Benzaldehyde 
 
 These results are typically diagnostic for a Type I allylation, implying that the 
silicon was also acting as a Lewis acid in order to engage the aldehyde in a closed transition 




 who reported 
uncatalyzed aldol additions to aldehydes from enoxysilacylobutanes. These observations 
were also unusual since silyl enol ethers were then known to require external Lewis acids to 
activate the aldehyde and promoting nucleophiles to attack the silicon in order to participate 
in Mukaiyama aldol reactions
28
. This newly discovered behavior of silicon acting as a 







. This behavior is a consequence from the compression of the C-Si-C bond 
angle in the silacyclobutane ring
30
 which is about 78° compared to an ideal tetrahedral angle 
of 109°. One can imagine that such compression is due to longer Si-C bond lengths (1.894 
Å) compared to typical C-C bond lengths in a cyclobutane (1.523 Å). As a result of this 
compression, this highly strained silacycle is very prone to accept nucleophiles or Lewis 
bases to adopt a trigonal bipyramidal hybridization to better accomodate the small angle
31
; 
thus, releasing the strain.  
 Not long after the observations by Utimoto, the Leighton group found that 
oxasilacyclopentane 1.3 also reacted with benzaldehyde under similar conditions
32
 as the 
silacyclobutane 1.1 (Scheme 1-15). While the 95° O-Si-C angle
33
 in 1.3 is larger than in 1.1, 
it was still strained enough to act as a Lewis acid aided by the electron withdrawing power 
of the neighboring oxygen.  
Scheme 1-15: Allyloxasilacyclopentane Reaction with Benzaldehyde 
 
1.2.1. Chiral Strained Allylsilicon Reagents 
This experimental result opened a new avenue for the discovery of potential chiral 
strained silane reagents such as the (S,S)-pseudoephedrine-derived silane
34
 1.4. Although 
1.4 exists as a 2:1 ratio of diastereomers, it reacts with several aldehydes (aromatic, alkenyl, 
aliphatic, branched, hindered, and α-oxyaliphatic) to give the corresponding homoallylic 





best advantage of this reagent is that each enantiomer of the pseudoephedrine precursor is 
readily available and very inexpensive. Also, this silane can be easily synthesized and 
purified in large scales and stored for long periods of time in a freezer
35
. 
Table 1-1: Pseudoephedrine-Derived Silane Asymmetric Allylation of Aldehydes 
 
 A similar system was later designed with strained chiral diaminocyclohexane-





 reactions with a wide range of aldehydes, proving to be 
even more selective than 1.4. A representative example is given for hydrocinnamaldehyde 
(Scheme 1-16).  






 A powerful feature of the chiral diamine reagent is that it can override the inherent 
selectivity of chiral aldehydes in allylation reactions; thus, completely controlling the 
diastereochemical outcome in the product (Scheme 1-17).  
Scheme 1-17: Asymmetric Allylation of Chiral Aldehydes 
 
 Several expansions in asymmetric allylation of the carbonyl group were later 
reported from the Leighton group
38
, some of which will be discussed in Chapter 4, leading 
to the discovery of an asymmetric catalytic system for aldehydes using achiral strained 
silanes.  





 N-acylhydrazones in a highly enantioselective manner 
(Scheme 1-18).  
Scheme 1-18: Enantioselective Allylation of N-acylhydrazones 
 
 However, there is an important structural requirement for the imine that must be met 





silanes. That major requirement is that the imine must bear a protic nucleophile, which has 
the crucial role of binding to the silane to displace the chloride. This occurs with 
concomitant generation of HCl, which protonates the pseudoephedrine backbone and 
provides a positive charge adjacent to the silicon; thus, further enhancing its Lewis acidity. 
In fact, when benzoyl hydrazone 1.6 is mixed with equimolar amounts of silane 1.6, a 
single complex 1.7 can be isolated, and its crystal structure clearly depicts the product of 
this process
41
 (Scheme 1-19). Additionally, it was observed that the imine had isomerized 
from (E) to (Z), which will play an important role later in our discussions about the 
diastereoselective outcome of crotylation and cinnamylation reactions. As further support to 
these findings, no reaction was observed when the chloride in the silane was replaced by 
methoxy or when the N-H proton in the hydrazone was replaced by methyl. The former 
observation due to the fact that methoxy is a lousy leaving group, so it does not get 
displaced, and even if it did, the resulting methanol would not protonate the nitrogen in the 
pseudoephedrine backbone. The latter observation is attributed to the lack of an available 












Scheme 1-19: Silane Hydrazone Complexation and X-Ray Characterization 
 
 
  Unfortunately, the acyl hydrazones did not perform well in crotylation reactions
42
 
and the cleavage of the hydrazide products with samarium iodide to give the free amine was 
not ideal in terms of practicality and scalability. Since then, the Leighton group has begun a 
search for an ideal imine activating group that meets the requirements described above in an 
effort to broaden the scope of allylation reactions. This ideal activating group must not only 
facilitate the reaction, but also must be readily cleavable from the products in an efficient, 
orthogonal, and user-friendly manner so that the synthetic utility of the homoallylic amine 
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CHAPTER 2  
The Asymmetric Allylation of N-Heteroaryl Hydrazones 
2.1. Introduction 
Chiral amines are innately important as they are commonly identified in biologically 
active natural products and pharmaceutical compounds
1
. Asymmetric nucleophilic addition 
to imines is perhaps the most widely used approach to make such compounds in high levels 
of enantioselectivity. One attractive transformation of this sort is the asymmetric allylation 
of imines since the corresponding products display several useful structural features such as 
an additional stereocenter adjacent to that of the carbinamine position and two synthetically 
valuable functionalities such as the terminal olefin and the amine nitrogen (Figure 2-1).  
Figure 2-1:   Generic Asymmetric Allylation of Imines
 
However, current methods available for the asymmetric synthesis of chiral 
homoallylic amines are generally limited in substrate scope (mostly effective for R
1
 = 
aromatic). Moreover, the geometric availability/stability of the chiral metal ([M]*) allyl 
fragment coupling partners (cis vs. trans R
3
) can be a difficult issue to deal with as the 
complexity of R
3
 increases. In addition, chiral ligands on the metal can be expensive and/or 
cumbersome to access synthetically. Furthermore, some systems require the use of non-
trivially made synthetic scaffolds as imine activating/directing groups (R
2





also problematic to remove orthogonally and efficiently in a user-friendly manner
2
. In the 
search for a novel and efficient method for asymmetric imine allylation, the Leighton group 
has reported the use of inexpensive chiral strained silane (S,S)-2.1 as a Lewis acid for the 
allylation of aldehyde and ketone derived acyl hydrazones with moderate to excellent yields 
and good to excellent levels of enantioselectivity (Scheme 2-1)
3
.  
Scheme 2-1: Enantioselective Allylation of N-Acylhydrazones 
 
Despite the usefulness of this methodology, the substrate scope was limited to 
aromatic acyl hydrazones. In addition, these hydrazones did not perform well in crotylation 
and cinnamylation reactions. In order to address this problem, a new class of aminophenol 
and aminomethylphenol-derived imines was developed. These new imines were found to be 
suitable for the previously mentioned reactions using the corresponding Leighton reagents 












Scheme 2-2: Asymmetric Allylation of Aminophenol-derived Imines 
 
Scheme 2-3: Asymmetric Allylation of Aminomethylphenol-derived Imines 
 
However, the problem of expanding the scope to aliphatic substrates remained in 
place as well as the removal of the N-bearing motif or activating group from the product. 
The cleavage protocols used for these groups in the previously mentioned methodologies 
were inconvenient, non-scalable, and in cases non-orthogonal since reagents such as 
samarium iodide and strong oxidants must be used. With these challenges in mind, the 
Leighton group continued its research journey by looking for an ideal activating group that 
provides both reactivity with the Leighton reagents and enough lability for efficient 







2.2. N-Hetrocyclic Hydrazones in perspective with the Leighton Silanes 
The search for an ideal activating group led to the discovery of a new class of N-
heteroaryl hydrazones
5
. These hydrazones were envisioned to react in a similar way as the 
acylhydrazones did with silane 2.2 to promote allyl transfer (Scheme 2-4)
6
.  
Scheme 2-4: N-Heteroaryl Hydrazones as Protic Nucleophiles to Leighton Allyl Silanes 
 
Note that the requirement of having a protic nucleophile tethered to the imine 
nitrogen, circled in Scheme 2-4 for emphasis, could be met by tautomerization of the 
corresponding hydrazone. Even though it is required that the heterocycle loses its 
aromaticity, this is not necessarily a problematic issue since the heterocycle already 
displays depressed aromatic character. This is a consequence from the electron withdrawing 
power of nitrogen which results in unequal sharing of the electron density in the ring and 
different N-C and C-C bond lengths.
7
 In addition, it was envisioned that the N-N hydrazide 
bond in the resulting product could be cleaved by metal-catalyzed hydrogenation
8
 in 






The preparation of N-heteroaryl hydrazones is conveniently achieved by 
condensation of the desired aldehyde with an N-heteroaryl hydrazide. Some of the 
hydrazides are commercially available or inexpensively prepared from their corresponding 
dichloroheteroarene precursor
9
 (Scheme 2-5). 
Scheme 2-5: A Typical Preparation of N-Heteroaryl Hydrazones
 
2.3. Asymmetric Allylation and Crotylation of  N-Heterocyclic Hydrazones 
After exhaustive screening of several heterocyclic motifs
10
, it was found that 
benzoxazole-derived hydrazone 2.3 could be allylated with silane (R,R)-2.2 in 64% yield 
and 91% ee, and cleaved under mild hydrogenolysis conditions with Pearlman’s catalyst to 
give the corresponding free amine in 90% yield (Scheme 2-5).   






Similarly, 6-chloro-2-quinolyl-derived hydrazone 2.5 was subjected to silane (R,R)-
2.6 to give crotylation product 2.7 in 67% yield and 94% ee. This product was also cleaved 
via hydrogenolysis with Pearlman’s catalyst (Scheme 2-6) to give its free amine in 98% 




Scheme 2-7: Crotylation/Cleavage of Benzoxazole-derived Hydrazones* 
 
 
2.4. Asymmetric Cinnamylation of N-Heterocyclic Hydrazones 
Unfortunately, none of the previously mentioned hydrazones performed well in the 
cinnamylation reaction with (R,R)-2.8. Thus, we attempted to screen several aryl motifs, 
silanes, and substrates (Figure 2-2) to fine-tune for an optimal single system for allylation, 





Figure 2-1: Proposed Variable Changes for Screening
 
Table 2-1: Screen Results 
 
Unfortunately, the results presented in Table 2-1 clearly show that stereoselectivities 





moderate to good range in most cases. The pyrimidine motif for instance gave the best 
yields albeit with terrible stereoselectivities (Entries 1-2). The pyridazine motif showed a 
particular substrate dependency for its corresponding hydrocinnamaldehyde derived 
hydrazone in terms of selectivity, but it followed no trend in terms of yields or ee’s for other 
substrates or silanes (Entries 3-9). While we could not unify this methodology by using a 
single N-heteroaryl motif, the most optimal result for the cinnamylation reaction with (S,S)-
2.8 was observed for the chloropyridazyl hydrocinnamaldehyde-derived hydrazone which 
gave its cinnamylation product in 82% yield and 85% ee (entry 10). It seems as if the 
relative position of both the nitrogens and the chlorine atom in the heteroaryl motif play a 
crucial role for selectivity perhaps due to a stereoelectronic effect. We attempted to probe 
this by exchanging the chlorine atom in the quinoline series (heteroaryl B, Figure 2-2) for a 
methoxy group, but this dramatically affected the reactivity of the system and resulted in no 
reaction.  
2.5. Tandem Cross-Metathesis/Cinnamylation of N-Heterocylic Hydrazones 
We further explored the performance of chloropyridazyl-derived hydrazones in a 
previously established tandem cross-metathesis/cinnamylation protocol
12
. This protocol 
consists of generating cinnamyl-like silanes in situ by reacting allylsilane 2.1 with a styrene 
of choice and catalytic amounts of Grubbs-II catalyst in refluxing CH2Cl2, CHCl3, or DCE.   
Subsequently, the hydrazone is added to the same reaction pot to proceed with the allyl 
transfer. One of the most attractive features of this protocol is that one can streamline the 





starting materials in one step. This bypasses the need to design a de novo synthesis of the 
each desired allylation reagent, which in cases may be non-isolable. Thus, this protocol 
provides a great avenue to access a wide range of potentially useful chiral substituted 
homoallylic carbinamines.  
In order to explore the previously mentioned protocol, we picked the 
hydrocinnamyl-pyridazyl-derived substrate (Table 2-1, entry 10) given that it performed 
best in the cinnamylation reaction with isolated silane (S,S)-2.8. In the tandem protocol; 
however, we found that the resulting hydrazide 2.9 was obtained in about a 2:1 ratio to its 
N-N bond oxidized diazine analogue 2.10 (Table 2-2).  In addition, other aliphatic 
substrates underwent this protocol with considerably lower yields and selectivities. 
Table 2-2: N-Heteroaryl Hydrazones in Tandem CM/Cinnamylation Reactions 
 
 
While we rigorously attempted to suppress oxygen from the reaction and even added 





diazine product. Thus, we attributed the oxidation to be most likely due to ruthenium 
species remaining from the cross-metathesis as there is precedence that these species can 
catalyze N-N bond dehydrogenation
13
.  We also noted that the added yields of 2.9 and 2.10 
were comparable to the yield of the direct cinnamylation with (S,S)-2.8 with unaltered 
stereoselectivities. Since it was cumbersome to isolate two different species as product, we 
decided to treat the entire reaction crude mixture under different oxidizing conditions to 
convert all of the hydrazide product to its diazine analogue (Table  2-3). 
Table 2-3: Redox Conditions on Crude CM/Cinnamylation Reactions 
 
 
We were pleased to find that upon stirring the CM/cinnamylation crude contents 
with a 2:1 mixture of dichloromethane and hydrogen peroxide (Table 2-3, entry 5), all of 
the hydrazide product was converted to its corresponding diazine. With these findings, we 





electron rich, heterocyclic, and hindered) and vinyl cyclohexane (Table 2-4). Reactions 
gave moderate yields and good to excellent stereoselectivities.   
Table 2-4: Tandem CM/Cinnamylation of N-Heteroaryl Hydrazones 
 
 
2.6. Cleavage of the N-Heteroaryl Activating Group 
Having established a reliable method for the tandem CM/Cinnamylation described 
above, we turned our attention to the cleavage of the N-N bond of the corresponding diazine 
products. While these diazines were susceptible to hydrogenation conditions with Pd(OH)2, 
attempts to purify the resulting free amine were unsuccessful as we obtained instead the N-





the chloropyridazyl motif, presumably with palladium serving as a Lewis acid to activate 
one of the nitrogens in the heterocycle (Scheme 2-8).  
Scheme 2-8: Direct Cleavage of Diazine Products with Pd(OH)2 
 
Attempts to protect the crude free amine with benzoyl chloride, acetyl chloride, di-
tert-butyl dicarbonate, acetic anhydride, and trifluoroacetic anhydride, only afforded either 
the mono- and/or bis-acylated versions of 2.11. 
To circumvent this problem, we attempted to reduce and replace the chloride 
substituent on the heteroaryl motif since it was responsible to engage in the undesired SNAr 
pathway. Unfortunately, these attempts only gave the corresponding ketimine 2.12, 
destroying the carbinamine stereocenter (Scheme 2-9) 






Interestingly, we found that hydrogenating the hydrazide products with Pd/C and 




Scheme 2-10: Direct Reduction with Pd/C in Basic Conditions 
 
We found that sodium hydroxide was not necessary to reduce the chloride, so we 
removed it from the protocol above. This allowed us to carry the crude dehalogenated 
diazine into a second stage hydrogenation with Pearlman’s catalyst to effect the desired N-
N bond cleavage to obtain 2.14 in 89% yield over two steps (Scheme 2-11).  







2.7. Stereochemical Proofs 
The relative and absolute configuration of the compounds listed in Table 2-4 were 
determined by means of converging to known compounds in the literature. The enantiomer 
of cleaved cinnamylation product 2.14 was benzoylated to give benzamide 2.15, which was 
directly compared to the analogous benzamide 2.16 obtained from the method of Loh and 
coworkers
15
. Absolute stereochemistry was determined by comparing the optical rotation of 
the two benzamide samples (Scheme 2-12).  
Scheme 2-12: Stereochemical Proof for the CM/Cinnamylation Products 
 
2.8. Stereochemical Rationale  
Some mechanistic insights were obtained to rationalize the stereochemical outcome 
of the cinnamylation products. As expected, the N-heteroaryl motif on the hydrazone 2.17 




Si NMR the formation of a new single complex over time, presumably 2.19. For instance, 





indicative of N-Me protonation. This protonation can result from the hydrazone attacking 
the silicon, displacing the chloride and generating an equivalent of HCl which should be 
scavenged by the N-Me moiety
16
. Moreover, the 
29
Si NMR spectrum shows a new single 
peak at -92 ppm, which corresponds to the chemical shift of a pentacoordinate silicon 
species
17
. This finding implies that the imine nitrogen is participating in coordination to the 
silicon to form the pentacoordinate species, which is consistent to the original reported 
crystal stucture for coodination of acyl hydrazones and silane 2.18
18
 (Scheme 2.13).  
Scheme 2-13: N-Heteroaryl Hydrazones and Complexation to Leighton Phenyl Silane 
 
Using these clues along with the observed stereochemical outcomes of the reaction, 
we propose that a generic N-heteroaryl hydrazone 2.20 binds the chlorosilane 2.21, 
providing a six-member closed transition state for the subsequent cinnamyl transfer 
(Scheme 2-14). While this is plausible based on the experimental stereochemical outcomes 
of the reaction, we cannot generalize this transition state for other substrates besides the 
hydrocinnamaldehyde-pyridazyl-derived hydrazones as the yields and stereoselectivities 
were across the board when varying substrate and/or aryl motifs. This observation is 









We have developed a method for asymmetric allylation, crotylation, and 
cinnamylation of several aliphatic N-heteroaryl hydrazones. We have been able to introduce 
these substrates into a tandem cross-metathesis/cinnamylation/oxidation protocol which 
allowed for the synthesis of more diversely substituted cinnamyl products in moderate 
yields and good to excellent stereoselectivities. We have also demonstrated that these N-
heteroaryl motifs on our products can be readily and efficiently cleaved by catalytic 
hydrogenation to unmask the corresponding free amine without the use of inefficient, 
expensive, or toxic multistep protocols. While these new methodologies have improved the 
scope and synthetic utility of the Leighton allylation, further studies should be devoted to 
the development of an even better activating group that is readily cleaved without the use of 
metals and in such a way as to preserve the synthetically valuable aryl halides and terminal 
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2.11. Experimental Section 
All reactions were carried out under an atmosphere of nitrogen in flame- or oven-
dried glassware with magnetic stirring unless otherwise indicated. Degassed solvents were 
purified by passage through an activated alumina column. Absolute ethanol was purchased 
from Pharmco Inc. and used without purification. 3,6-dichloropyridazine, (1R,2R)-
pseudoephedrine and aldehyde reagents unless otherwise indicated were purchased from 
Aldrich. 
1
Aldehydes were distilled before use and stored at -20 °C. 
1
H NMR spectra were 
recorded on a Bruker spectrometer of the field strength indicated in the experimentals at 
25°C and are reported in ppm from TMS internal standard (0.0 ppm). Data are reported as 
follows: (s=singlet, br s=broad singlet, d=doublet, t=triplet, q=quartet, quin=quintet, 
m=multiplet, dd=doublet of doublets, td= triplet of doublets; coupling constant(s) in Hz; 
integration; assignment). Proton decoupled 
13
C NMR spectra were recorded on a Bruker 
spectrometer at the indicated field strength at 25 °C and are reported in ppm from CDCl3 
internal standard (77.0 ppm). Infrared spectra were recorded on a Perkin Elmer Paragon 
1000 FT-IR spectrometer. Mass spectra were recorded on a JEOL LCmate spectrometer.  
Optical rotations were recorded on a Jasco DIP-1000 digital polarimeter.  
 
 
                                                          
1
 Silane reagents and precursors were prepared according to previously reported procedures: 
Tsuji, J.; Hara, M.; Ohno, K. Tetrahedron 1974, 30, 2143-2146. (b) Furuya, N.; Sukawa, T. J. Organomet. 
Chem. 1975, 96, C1-C3. (c) Kira, M.; Hino, T.; Sakurai, H. Tetrahedron Lett. 1989, 30, 1099-1102. (d) Iseki, 
K.; Kuroki, Y.; Takahashi, M.; Kishimoto, S.; Kobayashi, Y. Tetrahedron 1997, 53, 3513-3526. (e) Kinnaird, 






Typical  Procedure for the preparation N-Heteroaryl Hydrazones. Generation of the 
arylhydrazine: To a stirring solution of the corresponding dichlorodiazine (6.71mmol) in 
absolute ethanol (20 mL) at room temperature, hydrazine hydrate (57.1 mmol) was added 
via syringe dropwise. The orginally brown solution starts yielding white precipitate in about 
5 minutes. The reaction mixture was then cooled to 0
o
C, and the precipitate was collected 
via vacuum filtration and rinsed with chilled ethanol. The resulting white solid can be 
further azeotroped with toluene to remove any moisture and dried under high vacuum. The 
collected solid is the desired product and can be used without further purification.  
 Generation of the pyridazyl-derived hydrazone: To a stirring suspension of the 6-
chloro-3-hydrazinopyridazine (2.56 mmol) in absolute ethanol (12 mL) was added 
hydrocinnamaldehyde (2.56 mmol) dropwise at room temperature then heated to reflux for 
4 h. After cooling to room temperature, the resulting precipitate was collected under 
vacuum filtration, dried, and used without further purification. 
 
General procedure for the Cross-Metathesis/cinnamylation of pyridazylhydrazones: 
To a solution of the vinylarene or vinylalkane (2.150 mmol) in either chloroform (CHCl3) 
or dichloromethane (CH2Cl2) (3 mL) is added (R,R)-allylsilane reagent (0.430 mmol) 
followed by the second generation Grubbs catalyst (11 mg, 3.0 mol% based on (R,R)-
allylsilane). The resulting mixture is heated at reflux for 7 h (CH2Cl2) or 5 h (CHCl3) and 
then cooled to room temperature. The pyridazylhydrazone (0.192 mmol) is then added. 
Depending on the vinylarene or vinylalkane of choice, the reaction is run at room 
temperature or at 0
o





mixture is concentrated down and rediluted in CH2Cl2 (10 mL) and hydrogen peroxide 30 
wt. % solution in water (5 mL) and allowed to stir vigorously for 4 h at room temperature. 
The organic phase is separated. The aqueous layer is extracted with additional amounts of 
CH2Cl2 (10 mL). The combined organics are washed with brine (10 mL) and dried over 
magnesium sulfate, filtered, and concentrated. The residue is purified by column 
chromatography on silica gel to obtain the desired product. 
3-chloro-6-(2-((3R,4S)-1,4-diphenylhex-5-en-3-yl)hydrazinyl)pyridazine (2.9): The 
reaction was carried out in dichloromethane at 0
o
C according to the general procedure with 
the exception of the oxidation step. The crude was directly purified without work up by 
flash chromatography in silica gel (0-40 % ethyl acetate/hexanes) to give 40 mg (55%) of 
the title compound.  
1
H NMR (400 MHz, CDCl3) δ 7.32 (t, J = 7.3 Hz, 2H, Ar-H), 7.28 – 
7.22 (m, 4H, Ar-H), 7.22 – 7.07 (m, 5H, Ar-H), 6.95 (d, J = 7.1 Hz, 2H, Ar-H), 6.82 (s, 1H, 
ArN-H), 6.15 (dt, J = 17.1, 9.8 Hz, 1H, CHCH=CH2), 5.32 – 5.19 (m, 2H, CH=CH2), 4.14 
(s, 1H, CHNHNHAr), 3.52 (t, J = 9.0 Hz, 1H, PhCHCH=CH2), 3.20 (dd, J = 12.0, 7.5 Hz, 
1H, CH2CHNH), 2.62 (tdd, J = 13.9, 10.4, 4.3 Hz, 2H, PhCH2), 1.82 – 1.49 (m, 2H, 
CH2CHNH). 
13
C NMR (400 MHz, CDCl3) δ 162.37, 148.12, 142.01, 141.64, 139.28, 
129.86, 129.29, 128.78, 128.65, 128.32, 127.30, 126.30, 117.99, 116.37, 77.75, 77.44, 
77.12, 63.66, 53.61, 32.50, 31.50. IR (thin film): 3218.10 (m), 3060.29 (m), 3025.17 (m), 
2921.02 (m), 1600.21 (s). HRMS (FAB+) calculated for C22H24ClN4: 379.1689, observed: 
379.1690 (M+H); [α]D
23 
 = -13 (c 3.00, CHCl3). 
3-chloro-6-((E)-((3R,4S)-1,4-diphenylhex-5-en-3-yl)diazenyl)pyridazine (2.10): The 
reaction was carried out in dichloromethane at 0
o





product was purified by flash chromatography in silica gel (0-10 % ethyl acetate/hexanes) 
to give 45 mg (62%) of the corresponding diazine. 
1
H NMR (400 MHz, CDCl3) δ 7.65 (d, J 
= 9.0 Hz, 1H, Ar-H), 7.52 (d, J = 9.0 Hz, 1H, Ar-H), 7.35 (t, J = 7.3 Hz, 2H, Ar-H), 7.28 – 
7.18 (m, 5H, Ar-H), 7.18 – 7.10 (m, 1H, Ar-H), 7.04 (d, J = 7.0 Hz, 2H, Ar-H), 6.05 – 5.90 
(m, 1H, CHCH=CH2), 5.10 – 4.96 (m, 2H, CH=CH2), 4.32 (td, J = 9.1, 3.1 Hz, 1H, 
CHN=NAr), 4.07 (t, J = 8.8 Hz, 1H, PhCHCH=CH2), 2.50 (t, J = 7.6 Hz, 2H, PhCH2), 2.38 
– 1.93 (m, 2H, CH2CHNNAr). 
13
C NMR (400 MHz, CDCl3) δ 164.33, 158.36, 141.44, 
140.98, 139.16, 130.79, 129.30, 128.84, 128.77, 128.70, 127.44, 126.31, 119.22, 117.18, 
82.57, 77.73, 77.42, 77.10, 54.41, 33.38, 32.60. IR (thin film): 3056.52 (w), 3026.62 (w), 
2921.20 (m), 2850.84 (w). HRMS (FAB+) calculated for C22H22ClN4: 377.1533, observed: 
377.1541 (M+H); [α]D
23
 = -84 (c 1.00, CHCl3). 
3-chloro-6-((E)-((3R,4S)-1-phenyl-4-o-tolylhex-5-en-3-yl)diazenyl)pyridazine (Table 2-
4, entry 2): The reaction was carried out in chloroform at 0
o
C according to the general 
procedure. The product was purified by flash chromatography in silica gel (0-10 % ethyl 
acetate/hexanes) to give 53 mg (71%) of the corresponding diazine. 
1
H NMR (400 MHz, 
CDCl3) δ 7.66 (d, J = 9.0 Hz, 1H, Ar-H), 7.56 (d, J = 9.0 Hz, 1H, Ar-H), 7.17 (dddd, J = 
24.9, 23.2, 9.4, 6.8 Hz, 7H, Ar-H), 7.03 (d, J = 7.0 Hz, 2H, Ar-H), 5.87 (ddd, J = 16.7, 10.8, 
8.3 Hz, 1H, CHCH=CH2), 4.95 (dd, J = 11.4, 5.6 Hz, 2H, CH=CH2), 4.47 – 4.31 (m, 2H, 
PhCH-CHN=NAr), 2.49 (t, J = 7.8 Hz, 2H, PhCH2), 2.44 (s, 3H, Ar-CH3), 2.49 – 1.97 (m, 
2H, CH2CHNNAr). 
13
C NMR (400 MHz, CDCl3) δ 164.30, 158.34, 141.36, 139.20, 139.03, 
136.51, 131.32, 130.78, 128.88, 128.76, 127.70, 127.04, 126.93, 126.31, 119.37, 116.88, 





(w), 2921.82 (m), 1494.84 (m). HRMS (FAB+) calculated for C23H24ClN4: 391.1689, 
observed: 391.1700 (M+H); [α]D
23
 = -78 (c 1.7, CHCl3). 
 
3-chloro-6-((E)-((3R,4S)-1-phenyl-4-p-tolylhex-5-en-3-yl)diazenyl)pyridazine (Table 2-
4, entry 3): The reaction was carried out in dichloromethane at room temperature according 
to the general procedure. The product was purified by flash chromatography in silica gel (0-
10 % ethyl acetate/hexanes) to give 51 mg (68%) of the corresponding diazine. 
1
H NMR 
(400 MHz, CDCl3) δ 7.64 (d, J = 9.0 Hz, 1H), 7.52 (d, J = 9.0 Hz, 1H), 7.22 (t, J = 7.3 Hz, 
3H, Ar-H), 7.13 (dd, J = 20.1, 8.0 Hz, 5H, Ar-H), 7.04 (d, J = 7.0 Hz, 2H, Ar-H), 6.03 – 
5.89 (m, 1H, CHCH=CH2), 5.04 – 4.93 (m, 2H, CH=CH2), 4.30 (td, J = 9.1, 3.1 Hz, 1H, 
CHN=NAr ), 4.03 (t, J = 8.7 Hz, 1H PhCHCH=CH2), 2.50 (t, J = 7.9 Hz, 2H, PhCH2), 2.35 
(s, 3H, Ar-CH3), 2.34 - 1.95 (m, 2H, CH2CHNNAr). 
13
C NMR (300 MHz, CDCl3) δ 
164.30, 158.33, 141.50, 139.38, 137.90, 137.02, 130.80, 129.98, 128.84, 128.74, 128.51, 
126.28, 119.21, 116.91, 82.69, 77.84, 77.61, 77.41, 76.99, 54.05, 33.36, 32.64, 21.45. IR 
(thin film): 3000.00 (m) 2924.93 (s), 2854.38 (m), 1698.77 (m). HRMS (FAB+) calculated 
for C23H24ClN4: 391.1689, observed: 391.1678 (M+H); [α]D
23
 = +121 (c 0.50, CHCl3).  
3-chloro-6-((E)-((3R,4S)-1-phenyl-4-(3-(trifluoromethyl)phenyl)hex-5-en-3-
yl)diazenyl)pyridazine (Table 2-4, entry 4): The reaction was carried out in chloroform at 
0
o
C according to the general procedure. The product was purified by flash chromatography 
in silica gel (0-10 % ethyl acetate/hexanes) to give 25 mg (62%) of the corresponding 
diazine. 
1
H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 9.0 Hz, 1H, Ar-H), 7.52 (d, J = 8.9 Hz, 





= 7.3 Hz, 1H, Ar-H), 7.05 (d, J = 7.0 Hz, 2H, Ar-H), 6.02 (ddd, J = 17.0, 10.2, 8.8 Hz, 1H, 
CHCH=CH2), 5.10 (dd, J = 12.9, 11.5 Hz, 2H, CH=CH2), 4.31 (td, J = 8.8, 3.3 Hz, 1H, 
CHN=NAr), 4.13 (t, J = 8.5 Hz, 1H, PhCHCH=CH2), 2.61 – 2.46 (m, 2H, PhCH2), 2.39 - 
1.90 (m, 2H, CH2CHNNAr). 13C NMR (400 MHz, CDCl3) δ 164.23, 158.47, 142.10, 
141.08, 137.93, 132.03, 130.81, 129.76, 128.86, 128.84, 126.47, 125.56, 124.34, 119.16, 
118.27, 82.00, 77.74, 77.43, 77.11, 54.10, 33.25, 32.47. IR (thin film): 3082.61 (w) 3056.52 
(w), 3026.09 (w), 2922.00 (m). HRMS (FAB+) calculated for C23H21ClN4F3: 445.1407, 
observed: 445.1393 (M+H); [α]D
23
 = +91  (c 0.8, CHCl3). 
3-chloro-6-((E)-((3R,4S)-4-(4-fluorophenyl)-1-phenylhex-5-en-3-yl)diazenyl)pyridazine 
(Table 2-4, entry 5) : The reaction was carried out in dichloromethane at 0
o
C according to 
the general procedure. The product was purified by flash chromatography in silica gel (0-10 
% ethyl acetate/hexanes) to give 50 mg (66%) of the corresponding diazine.  
1
H NMR (400 
MHz, CDCl3) δ 7.65 (d, J = 9.0 Hz, 1H, Ar-H), 7.52 (d, J = 9.0 Hz, 1H, Ar-H), 7.23 (t, J = 
7.3 Hz, 2H, Ar-H), 7.19 – 7.11 (m, 3H, Ar-H), 7.03 (t, J = 8.7 Hz, 4H, Ar-H), 5.95 (ddd, J 
= 16.9, 10.3, 8.7 Hz, 1H, CHCH=CH2), 5.11 – 4.93 (m, 2H, CH=CH2), 4.27 (td, J = 9.1, 3.1 
Hz, 1H, CHN=NAr), 4.06 (t, J = 8.6 Hz, 1H, PhCHCH=CH2), 2.65 – 2.42 (m, 2H, PhCH2), 
2.52– 1.85 (m, 2H, CH2CHNNAr). 
13
C NMR (300 MHz, CDCl3) δ 164.25, 158.39, 141.28, 
138.83, 136.69, 130.79, 130.17, 130.07, 128.81, 126.37, 119.19, 117.40, 116.26, 115.98, 
82.45, 77.82, 77.40, 76.98, 53.52, 33.33, 32.55. IR (thin film): 3027.00 (w) 2921.82 (m), 
2854.97 (w), 1601.99 (m), 1508.29 (s). HRMS (FAB+) calculated for C22H21ClN4F: 
395.1439, observed: 395.1435 (M+H); [α]D
23







(Table 2-4, entry 6): The reaction was carried out in dichloromethane at 0
o
C according to 
the general procedure. The product was purified by flash chromatography in silica gel (0-10 
% ethyl acetate/hexanes) to give 53 mg (72%) of the corresponding diazine in 5:1 dr 
(syn:anti). 
1
H NMR (400 MHz, CDCl3) δ 7.70 – 7.59 (m, 1H, Ar-H), 7.56 - 7.52 (m, 1H, 
Ar-H), 7.26 (d, J = 7.0 Hz, 2H, Ar-H), 7.22 – 7.06 (m, 3H, Ar-H), 5.85 (dt, J = 17.1, 10.2 
Hz, 1H, CHCH=CH2), 5.13 (ddd, J = 19.1, 13.7, 2.0 Hz, 2H, CH=CH2), 4.22 (dt, J = 9.2, 
4.8 Hz, 1H, CHN=NAr), 2.70 – 2.56 (m, 1H, CyCHCH=CH2), 2.51 – 2.37 (m, 2H, PhCH2), 
2.29 - 2.15 (m, 2H, CH2CHNNAr), 1.82 – 1.28 (m, 11H, Cy-H). 
13
C NMR (300 MHz, 
CDCl3) δ 164.40, 158.26, 141.77, 137.72, 130.78, 128.81, 126.32, 119.01, 118.20, 79.25, 
77.84, 77.42, 76.99, 54.76, 38.48, 34.00, 32.74, 31.32, 30.80, 26.72, 1.40. IR (thin film): 
3026.65 (w) 2924.85 (s), 2852.75 (s), 1589.77 (m). HRMS (FAB+) calculated for 
C22H28ClN4: 383.2002, observed: 383.1997 (M+H); [α]D
23





Chapter 3  
Asymmetric Allylation of Aminomethylnaphthol-derived Imines 
3.1 Introduction 
As discussed in the previous chapter, chiral homoallylic amines can be very 
valuable in the pharmaceutical and synthetic world as they can be used as small chiral 
building blocks given that they possess two major reactive functionalities: the amine 
nitrogen and the terminal olefin.  We have shown that developing versatile, efficient, and 
user-friendly methods to make this type of chiral amines has been a major research area 
within the Leighton group by means of using inexpensive chiral strained silane Lewis acids. 
We previously addressed the development of a novel method for the asymmetric allylation, 
crotylation, and cinnamylation of aliphatic N-heteroaryl hydrazones as well as a protocol to 
efficiently cleave the remaining heteroaryl motif from the resulting products. While this 
method had some attractive features, but it also had certain limitations: 1. It only works for 
aliphatic substrates, 2. Aryl halogens cannot be incorporated in the cleavage step as 
palladium is the hydrogenation catalyst, and 3. We were deleting the terminal olefin, which 
besides the newly acquired stereocenters is the next most valuable functionality in the 








Figure 3-1: Limitations in the N-Heteroaryl Hydrazones Allylation/Cleavage 
 
We decided to take a look back to the previously reported aminophenol and 
aminomethylphenol activating groups
1
 (Figure 3-2), which had performed wonderfully in 
the asymmetric allylation of their corresponding imines with the Leighton allyl silanes. Our 
major goal to revisit this methodology was to fix its most important limitation, which was 
the lack of an efficient, mild, and functional group tolerant cleavage protocol of these 
activating groups from the products.  
Figure 3-2: Aminophenol and Aminomethylphenol Activating Groups
 
Overcoming that limitation would be crucial in order to fully access the valuable 
synthetic utility inherent to the resulting free homoallylic amines. A clear instance of this 
limitation can be seen in the work by Amgen Inc.
2
 when they used the Leighton cross-
metathesis/cinnamylation protocol with the o-aminomethylphenol-derived imines
3
 to access 





hydrogenation conditions for the N-activating group cleavage due to the presence of aryl 
halides in the desired products, they had to resort to a four step sequence to obtain the free 
amines in low yields (Figure 3-3). Several calls from the pharmaceutical company have 
praised the academic and conceptual value of the allylation methodology, but it has also 
inquired about an efficient, mild, and orthogonal protocol for the N-activating group. 
Figure 3-3: A Real Case of Method Limitation: The Amgen Inc. Case 
 
 3.2. Cleavage of Aminophenol and Aminomethylphenol Activating Groups 
Initial attempts to remove the aminophenol activating group by oxidative cleavage 
from allylation products 3.3, prepared from imines 3.1, only resulted in major 
decomposition and only trace amounts of desired product. Instead, a multistep protocol was 
necessary to obtain only fair yields of the boc-amine 3.4
4
. This protocol required 
methylation of the phenol oxygen, reduction of the double of bond, followed by oxidation 
and in-situ protection of the resulting free amine (Scheme 3-1).     






Similarly, attempts to oxidatively cleave the aminomethylphenol activating group 
from allylation products 3.5, prepared from imines 3.2, followed by action of strong acids 
just resulted in over oxidation of the product and overall decomposition, failing to provide 
any desired amine 3.6
5
 (Scheme 3-2).  
Scheme 3-2: Attempted Cleavage of Aminomethylphenol-derived Homoallylic Amines 
 
In order to ultimately cleave the aminomethylphenol activating group, it was 
required to hydrogenate 3.5 with Pd(OH)2/C in order to obtain the free amines 3.7 in 
moderate yields
6
 at the expense of sacrificing the synthetic utility of the olefin and 
excluding the use of halogenated/pseudo halogenated aromatic substrates which play an 
important role in pharmaceutical research (Scheme 3-3). 
Scheme 3-3: Cleavage of Aminomethylphenol-derived Homoallylic Amines 
  
 The limitations in these just mentioned methodologies left us with an ample range of 





propose the next class of imine activating groups without having to redesign a whole new 
activating group from scratch. For instance, we noticed that in both attempts to oxidatively 
cleave the activating groups presented above, the existence of the double bond was always 
problematic. We believed that this olefin could potentially interact with highly reactive 
intermediates generated during oxidation such as o-quinone-methide monoimine
7
 as in the 
case of 3.3 and o-quinone-methide
8
 as in the case of 3.5. Thus, we focused our efforts in the 
development of analogous activating groups that could generate similar lower energy 
intermediates under milder and more user-friendly conditions with the possibility of adding 
trapping species, so we could obtain the desired free amines without the need to use 
invasive oxidations or resorting to the use of metals to cleave these groups.  This new class 
of activating groups will be directly related to the latter ones presented above only with 
minor structural changes but significantly different in reactivity: the o-
aminomethylnaphthol and the o-aminonaphthol groups.  
3.3. o-Aminomethylnaphthols as Activating Groups 
Looking further at the allylation products of 3.5, one can realize that the generation 
of the corresponding o-quinone methide 3.8 from that compound involves the disruption of 
aromaticity of a full benzene ring, requiring a high cost in energy. In fact, the generation of 
these species is well known to occur by means of high temperatures and photolysis 
protocols
9
. These conditions are not ideal given the presence of the olefin in the product and 
its suspected reactivity towards 3.8. We could potentially lower the energy required to 





the highly reactive species 3.8 would still be an issue. A perhaps better alternative is to both 
lower the energy required to generate an analogous intermediate and attenuate that 
intermediate’s reactivity. We envisioned that o-aminomethylnaphthol-derived amine 3.10 
would require less energy to generate its corresponding o-aminomethylnaphthoquinone 
methide 3.11 since disruption of aromaticity would not be as prohibitive as it would still 
contain the resonance stabilization energy of a full benzene ring
10
 (Scheme 3-4). For that 
same reason, reactivity of intermediate 3.11 would be expected to be lower. Thus, we could 
potentially utilize much milder conditions to generate 3.11 in the presence of a trapping 
species before it interacts with the terminal olefin of our products.  






 An advantageous feature of the required o-aminomethylnaphthol-derived imines is 
that they can be easily prepared from readily available and inexpensive starting materials in 




Scheme 3-5: Preparation of Aminomethylnaphthol-derived Imines 
 
3.4. Asymmetric Crotylation of o-Aminomethylnaphthol-derived Imines 
 With the imines in hand, we turned our attention to their performance in the 
crotylation reaction with silane (R,R)-3.12, and we were pleased to find out that they can 
afford the corresponding crotylation products in good yields, and excellent 
stereoselectivities (Table 3-1). Unfortunately, this crotylation protocol was only suitable for 
aromatic imine substrates. Subjecting cyclohexyl-derived imine substrate to (R,R)-3.12 
afforded the corresponding homoallylic amine in only 27% yield albeit excellent 








Table 3-1: Asymmetric Crotylation of o-Aminomethylnaphthol-derived Imines 
 
3.5. Asymmetric CM/Cinnamylation of o-aminomethylnaphthol-derived Imines 
 We found that these imines were also versatile substrates in the previously reported 
cross-metathesis/cinnamylation protocol
12
 with silane (R,R)-3.13. Reactions with several 
substituted styrenes and vinyl cyclohexane afforded the corresponding cinnamylation 
products (3.14 - 3.23) in better yields and excellent stereoselectivities (Table 3-2). 
Unfortunately, just like in the crotylation reactions, the aliphatic substrates did not perform 
well in this protocol. When subjecting hydrocinnamyl-derived imine substrate to the above 
conditions, we only obtained the corresponding product in 34% yield although with good 
enantioselectivity (24% ee) and excellent diastereoselectivity (>20:1 dr). By monitoring the 
reaction progress in the aliphatic case, we observed several unidentifiable side products by 
1
H NMR of the crude reaction mixture and also stronger fluorescence at the baseline by 





surprise since one potential issue with aliphatic imines in our protocol is that they could 
tautomerize to the enamine aided by the presence of a Lewis acid such as 3.12.  As a result, 
this enamine could then undergo other undesired reaction pathways.  









3.6. Cleavage of the N-(1-methyl-2-naphthol) Activating Group 
We focused our efforts to provide a generally user-friendly method that would allow 
us to cleave this newly designed motif. Inspired on structure 3.9, we hypothesized that we 
could lower the energy required to generate o-napthoquinone methide 3.11 by making the 
nitrogen on its homoallylic amine precursor 3.14 a better leaving group. Our initial attempts 
to generate 3.11 then consisted of refluxing the starting amines in the presence of strong 
acids. In this case, we were expecting that the protonated nitrogen would be a better leaving 
group. After screening several solvents, acids, and reaction conditions, we found no 
reaction other than the formation of the corresponding acid ammonium salt.  
Scheme 3-6: Thermal o-Naphthoquinone Methide Generation from Ammonium Salts 
 
We also took a look at acylating the nitrogen to facilitate its ejection when refluxing 
in presence of strong acids, but this just led to trace amount of products and mostly 
recovered starting material (Scheme 3-7).  






We also took a look at mild photolytic conditions
13
 in the presence of ethanedithiol, 
mercapto ethanol and vinyl ethers as the trapping agents, but we observed mostly starting 
material, trace product, and decomposition (Scheme 3-8). 
 
Scheme 3-8: Photolytic Generation of  o-Naphthoquinone Methide 
 
We decided to revisit the thermal conditions for the generation of 3.11 as we 
thought that the initial failures in Schemes 3.6 and 3.7 could be attributed to reversibility of 
the reaction
14
. One can imagine that once the amine is freed from the naphthol system, and 
the weakly nucleophilic counter ion of the acid attacks 3.11, the resulting substituted 
naphthol can regenerate 3.11 even more readily than from 3.10 as this counter ion is also a 
good leaving group.  
Next, we looked at thermal generation of 3.11 in the presence of strong 
nucleophiles
15
 without activating the nitrogen (Scheme 3-9). A wide range of nucleophiles 
was explored including thiols, sulfides, alcohols, vinyl ethers, and 1,3-dienes as trapping 
agents for 3.11 in several solvents (polar, non-polar, protic, aprotic) and temperatures, but 
no fruitful results were obtained as we either observed no reaction or major decomposition 





Scheme 3-9: Thermal Generation of o-Naphthoquinone Methide in Presence of Strong 
Nucleophiles 
 
We then turned our attention to other amines as possible trapping agents for 3.11. 
Page and coworkers reported that when 3.24 is refluxed in neat morpholine, it can afford 
the corresponding substituted o-phenol 3.26 in 51% yield
16
 (Scheme 3-10). We obtained 
compound 3.25 from our CM/Cinnamylation protocol and subjected it the reported cleavage 
conditions, but major decomposition was observed as the vinyl pattern of the terminal olefin 
disappeared in the 
1
H NMR spectrum. We also applied the reported conditions to 3.14, and 
observed similar results as in the previous case. Since in our hands Page’s cleavage of 3.24 
was completely reproducible, we attributed that the change in reactivity between  3.24 and 
homoallylic amines 3.14 and 3.25 was the presence of the terminal olefin in the latter two. 
At such high temperatures required for Page’s protocol, one can imagine that the rate of 
possible side reactions increases, resulting in major destruction of the desired product. 
Thus, we revisited our hypothesis that if o-naphthoquinone methide 3.11 was much more 
facile to generate, one could perhaps not require such high temperatures and infinitely large 







Scheme 3-10: Page’s Protocol for Thermal Cleavage in Morpholine 
 
We then set for screening several conditions in which we tested solvents, 
concentration of the amine nucleophile, and temperature. Analyzing the reaction progress 
for the thermal cleavage of 3.14 by 
1
H NMR, led us to find out that the best conversions to 
to 3.27 were in polar solvents (DCE, EtOAc, EtOH, CH3CN), with at least five equivalents 




C (Scheme 3-10). We picked our 
best and most convenient result, which was 100% conversion to 3.27 by heating a 0.1 M 
solution of 3.14 in absolute ethanol at 60
o
C with five equivalents of morpholine. We further 
explored other commercially available amines, especially focusing on those with low 





secondary amines were optimal in all cases as they gave 100% conversion to the desired 
product by 
1
H NMR with the exception of diisopropyl amine, which appeared to be too 
sterically hindered for our system (Scheme 3-11).  




While these were promising results, the protocol turned out to be impractical as we 
struggled to cleanly isolate 3.27 either by acid/base extractions or chromatography. In most 
cases we obtained low yields of 3.27 and recovered starting material 3.14. We attributed 
this result to reversibility of the reaction
17
,  aided by activation of 3.29 with Brønsted acids 
or silica gel. Neutralizing the silica gel or attempting to trap 3.27 in situ with several 





Scheme 3-12: Potential Reversible Pathway for the Cleavage Reaction
 
 We turned our attention to a carbon nucleophile such as pyrrole as the resulting 
carbon-carbon bond in the naphthol substituted product 3.30 would be stronger than that of 
the carbon nitrogen bond in 3.29. Indeed, we were pleased to find that pyrrole effected the 
cleavage cleanly as observed by 
1
H NMR under the same reaction conditions shown in 
Scheme 3-11. However,  we still ran into the problematic isolation of clean product, in 
which low yields persisted as well as recovery of starting material, which can be attributed 
to a retro electrophilic aromatic substitution aided by silica gel acting as a Lewis acid 
(Scheme 3-13).  






Attempts to optimize acid/base extraction work ups followed by chromatography 
only afforded 3.27 in 46% yield at most. Thus, we decided to explore in situ protection of 
3.27. After testing several acylating agents we found that di-tert-butyl dicarbonate was the 
best choice, affording the corresponding N-Boc protected homoallylic amines in good 
yields over two steps (Scheme 3-14). It is worth pointing out that this protocol is completely 
compatible with halogenated aromatic substrates and the terminal olefin in our products 











3.7. Stereochemical Proofs 
 In order to determine stereochemical outcome of the compounds listed in Scheme 3-





H NMR spectrum of 3.37 corresponded to the literature 
precedent, confirming the 1,2-anti relative stereochemistry.  Similarly, the optical rotation 
of  3.37 was compared to  the reported value, confirming the (1R,2S) absolute 
stereochemistry. (Scheme 3-15). 














3.8. Stereochemical Rationale 
Given that the stereochemical outcome of the cinnamylation products from imines 
3.38 listed in Scheme 3-14 was similar to the reported cinnamylation products from imines 
3.2
21
, we proposed that both types of imines are engaging in a similar closed transition state 
cis-3.40 to deliver the corresponding anti diastereomer (Figure 3-4).  
Figure 3-4: Proposed Transition State for the Cinnamylation of o-
Aminomethylnaphthol –derived Imines 
 
This proposed transition state minimizes steric interactions by placing R
1
 in a 
pseudoequatorial position, which requires a trans to cis isomerization of the imine
22
. This 
process can be operative from addition/elimination of the chloride from the Si-bound imine 
or directly from opening its  hemiaminal ether 3.41 by action of the silane as a Lewis acid 
(Figure 3-5). In fact, the starting material imines can be seen by 
1
H NMR as a mixture 
ranging from 0 – 100% of hemiaminalether : imine depending on the solvent of choice, 
which leads us to believe that this process is even more facile in the presence of Lewis acids 






Figure 3-5: Silane Catalyzed Imine E/Z Isomerization from its Hemiaminal Ether 
 
 Using the rationale presented in Figure 3.3, we redesigned the imine N-bearing 
motif in order to obtain the syn diastereomer product (Figure 3-6).  
Figure 3-6: Rationale for Proposed Imine N-bearing Motif Design 
 
 By increasing sterics at the carbon adjacent to the one bearing the nitrogen as in 
imines 3.42, one can envision that proposed transition state trans-3.43 would be more stable 
as it avoids severe steric interactions between the imine R
1
 substituent and the naphthol ring 
system in transition state cis-3.43. We attempted to test this hypothesis by synthesizing a 
variety of 1-hydroxy-2-aminoarenes (Figure 3-7) and subjecting their resulting imines to the 
CM/cinnamylation protocol. However, in most cases the aromatic systems themselves, or 





labile to air oxidation and would decompose almost right away on standing. Unfortunately, 
these observations impeded us from further exploration into this new kind of substrates.  
Figure 3-7: Aminoarenes Tested as Activating Groups 
 
3.9. Conclusions 
 Overall, we have developed a method for the asymmetric crotylation and 
cinnamylation of a new class of o-aminomethylnaphthol-derived imines with the 
corresponding pseudoephedrine-derived Leighton silane reagents. The imines are trivially 
and economically synthesized in large quantities, and the corresponding homoallylic amine 
products are readily and smoothly cleaved and in situ protected to generate the desired boc-
amines. Our method developed herein allows for taking advantage of the homoallylic amine 
products’ inherent functionality by avoiding the use of metals, which are known to be 
incompatible with aryl halides and the terminal olefin; thus, placing this method in a more 
synthetically powerful perspective. Further efforts on these studies should be aimed at 
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3.11. Experimental Section  
General Information. 
All reactions were carried out in flame-dried glassware under an inert atmosphere of 
nitrogen with magnetic stirring unless otherwise indicated. Methylene chloride and toluene 
were obtained from Fisher and purified by degassing with argon followed by passage 
through an activated neutral alumina column. Triethylamine was purchased from Alfa 
Aesar and purified by distillation from CaH2 then stored under nitrogen. Pentane (HPLC 
grade) was purchased from Fisher and used as received. Anhydrous chloroform (stabilized 
with amylenes) and 1,2-dichloroethane were purchased from Aldrich and used as received. 
Pyrrole was purchased from Aldrich and redistilled under reduced pressure from CaH2 then 
stored under nitrogen. The Grubbs second generation catalyst was obtained from Aldrich 
and used without further purification. Styrene was purchased from Alfa Aesar and used as 
received. Aldehydes and all other reagents were purchased from Aldrich and used as 





H NMR spectra were recorded on Avance III 400SL (400 MHz) or 
Avance III 500 Ascend (500 MHz) spectrometers. 
1H NMR chemical shifts (δ) are reported 
in parts per million (ppm) relative to tetramethylsilane internal standard (0 ppm) or DMSO-
d internal standard (2.50 ppm). Data are reported as follows: (s = singlet, br s = broad 
singlet, d = doublet, br d =broad doublet, t = triplet, q = quartet, quint = quintet, dd = 
                                                          
1
 Silane reagents and precursors were prepared according to previously reported procedures: 
Tsuji, J.; Hara, M.; Ohno, K. Tetrahedron 1974, 30, 2143-2146. (b) Furuya, N.; Sukawa, T. J. Organomet. 
Chem. 1975, 96, C1-C3. (c) Kira, M.; Hino, T.; Sakurai, H. Tetrahedron Lett. 1989, 30, 1099-1102. (d) Iseki, 
K.; Kuroki, Y.; Takahashi, M.; Kishimoto, S.; Kobayashi, Y. Tetrahedron 1997, 53, 3513-3526. (e) Kinnaird, 






doublet of doublets, dq = doublet of quartets, ddd = doublet of doublet of doublets, ddt = 
doublet of doublet of triplets, m = multiplet; integration; coupling constant in Hz; 
assignment). Proton decoupled 
13
C NMR spectra were recorded on Avance III 400SL (100 
MHz) or Avance III 500 Ascend (125 MHz) spectrometers and are reported in ppm from 
CDCl3 internal standard (77.16 ppm) or DMSO-d internal standard (39.52 ppm). 
29
Si NMR 
spectra were recorded on a Bruker DPX-300 (60 MHz) spectrometer and are reported with 
tetramethylsilane (0 ppm) as an internal standard. Infrared spectra were recorded on a 
Perkin Elmer Paragon 1000 FT-IR or Nicolet Avatar 370 DTGS spectrometers. Optical 
rotations were recorded on a Jasco DIP-1000 digital polarimeter; the concentration c is 
reported in g/100mL. Low resolution mass spectra were obtained on a JEOL HX100 mass 
spectrometer in the Columbia University Mass Spectrometry Laboratory. 
 
General Procedure for the Synthesis of 1-(aminomethyl)-2-naphthol-derived Imines 
To a suspension of 1-(aminomethyl)-2-naphthol hydrochloride (1.0 equiv) in ethanol 
(0.5M, 200 proof) is added anhydrous triethylamine (1.01 equiv.) followed by the 
corresponding aldehyde (1.0 equiv) and allowed to stir at room temperature for up to three 
hours. The resulting suspension is cooled to 0
o
C and filtered. The collected precipitate is 
rinsed with additional amounts of chilled ethanol and redissolved in CH2Cl2 and azeotroped 
with toluene under reduced pressure to remove any residual water. If needed the mother 
liquor can be further concentrated and chilled to collect a second or more crops of crystals. 
The resulting solid is further dried under vacuum and used without any further purification. 





form and their ratio varies depending on the solvent and the electronic nature of the starting 
aldehyde. 
For Imine thiophene-derived imine, crystallization from the reaction mixture was 
not observed. In this case, the ethanol was evaporated under reduced pressure, and the 
resulting residue was dissolved in ethyl acetate and extracted twice with water and then 
washed with brine. The organic layer was concentrated and azeotroped with toluene under 
reduced pressure to give the tittle compound as a crystalline solid.  
 
General Procedure for the Imine Crotylation Reactions  
To a solution of the imine (0.383 mmol) in CH2Cl2 (3.8 mL) is added (R,R)-3.12 
(0.575 mmol). The resulting solution is stirred at room temperature for 16 hr. The reaction 
mixture is diluted with ethyl acetate (20 mL) and extracted with brine (10 mL). The 
aqueous layer is reextracted with ethyl acetate (20 mL). The combined organic layers are 
dried (Na2SO4), decanted, and concentrated. The residue is purified by flash 
chromatography on silica gel (solvent gradient: 100% to 70% hexanes/ethyl acetate with 
1% triethylamine). 
 
General Procedure for the Cross-Metathesis/Imine Cinnamylation Reactions  
To a solution of the vinylarene or vinylheteroarene (1.440 mmol) in either 1,2-
dichloroethane (DCE), CHCl3, or CH2Cl2 (1.9 mL) is added (R,R)-3.13 (0.287 mmol) 
followed by the second generation Grubbs catalyst (9 mg, 3.0 mol% based upon (R,R)-





(CH2Cl2) and then cooled to room temperature. The imine (0.191 mmol) is then added. The 
reaction mixture is then heated at reflux for 14 h and then cooled to room temperature and 
quenched by the addition of ethanol (0.19 mL). The resulting mixture is diluted with ethyl 
acetate (10 mL) and extracted with brine (5 mL). The aqueous layer is reextracted with 
ethyl acetate (10 mL). The combined organic layers are dried (Na2SO4), decanted, and 
concentrated. The residue is purified by flash chromatography on silica gel (solvent 
gradient: 100% to 70% hexanes/ethyl acetate with 1% triethylamine). 
 
General Procedure for the Cleavage of the N-(1-methyl)-2-hydroxynaphthyl Group  
 To a solution of the amine (0.166 mmol) in ethanol (1.7 mL, 200 proof) is added 
pyrrole (0.830 mmol), and the contents are then stirred at 60
o
C for 1.5 h. The resulting 
solution is cooled to room temperature and concentrated under reduced pressure. The 
residue is redissolved in dichloromethane (1.7 mL) followed by addition of di-tert-butyl 
dicarbonate (Boc2O, 0.498 mmol) and triethylamine (0.332 mmol). The contents are 
allowed to stir at room temperature for 16 hrs. The reaction mixture is diluted in EtOAc (10 
mL) and extracted with water (5 mL). The organic layer is dried (Na2SO4), decanted, and 
concentrated. The residue is purified via column chromatography on silica gel (solvent 











1, Entry 1): 
1
H NMR (400 MHz, CDCl3) δ 7.77 – 7.56 (m, 3H), 7.46 – 7.21 (m, 7H), 7.10 
(d, J = 8.9 Hz, 1H), 5.81 (dt, J = 17.1, 9.5 Hz, 1H), 5.28 – 5.15 (m, 2H), 4.16 (dd, J = 93.4, 
14.3 Hz, 2H), 3.46 (d, J = 9.1 Hz, 1H), 2.55 (q, J = 8.5 Hz, 1H), 0.87 (d, J = 6.8 Hz, 3H). 
13
C NMR (126 MHz, CDCl3) δ 156.59, 141.20, 140.50, 132.24, 129.09, 128.82, 128.76, 
128.43, 127.97, 127.88, 126.19, 122.39, 121.10, 119.36, 117.00, 112.73, 67.82, 45.32, 
45.21, 18.18. IR (neat): 3293, 3062, 2969, 2923, 1622, 1599, 1515, 1454, 1356, 1270, 1237, 
1158, 999, 914, 814, 747, 701 cm
-1
. HRMS (FAB+) calculated for C22H24NO: 318.1858, 
observed: 318.1865 (M+H). [α]D
21
 = +74 (c 0.5, CHCl3). 
1-((((1R,2R)-1-(4-bromophenyl)-2-methylbut-3-en-1-yl)amino)methyl)naphthalen-2-ol 
(Table 3-1, Entry 2): 
1
H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 7.9 Hz, 1H), 7.68 (d, J = 
8.9 Hz, 1H), 7.60 (d, J = 8.7 Hz, 1H), 7.56 – 7.48 (m, 2H), 7.38 (ddd, J = 9.4, 6.5, 1.3 Hz, 
1H), 7.30 – 7.24 (m, 1H), 7.21 (d, J = 8.2 Hz, 2H), 7.10 (d, J = 8.8 Hz, 1H), 5.77 (ddd, J = 
16.9, 10.1, 8.9 Hz, 1H), 5.33 – 5.18 (m, 2H), 4.16 (dd, J = 102.6, 14.3 Hz, 2H), 3.44 (d, J = 
9.1 Hz, 1H), 2.50 (ddt, J = 15.6, 8.9, 6.8 Hz, 1H), 0.86 (d, J = 6.7 Hz, 3H). 
13
C NMR (101 
MHz, CDCl3) δ 156.42, 140.68, 139.61, 132.16, 131.93, 129.61, 129.17, 128.77, 128.45, 
126.24, 122.45, 121.67, 120.97, 119.26, 117.32, 112.48, 77.20, 67.31, 45.18, 18.01. IR 
(neat): 3291, 3063, 2972, 2927, 1621, 1597, 1517, 1485, 1467, 1406, 1373, 1336, 1270, 
1236, 1163, 1073, 1163, 1141, 1073, 1009, 913, 856, 815, 733, 687, 649 cm
-1
. HRMS 
(FAB+) calculated for C22H23BrNO: 396.0963, observed: 396.0955 (M+H). [α]D
21
 = +107 






ol (Table 3-1, Entry 3): 
1
H NMR (400 MHz, CDCl3) δ 7.76 – 7.71 (m, 1H), 7.66 (d, J = 
8.9 Hz, 1H), 7.62 (d, J = 8.5 Hz, 1H), 7.41 – 7.31 (m, 1H), 7.26 (dd, J = 8.1, 6.2 Hz, 3H), 
7.10 (d, J = 8.8 Hz, 1H), 6.99 – 6.90 (m, 2H), 5.80 (dt, J = 17.0, 9.4 Hz, 1H), 5.28 – 5.14 
(m, 2H), 4.16 (dd, J = 94.0, 14.4 Hz, 2H), 3.84 (s, 3H), 3.41 (d, J = 9.2 Hz, 1H), 2.58 – 2.44 
(m, 1H), 0.86 (d, J = 6.8 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 159.19, 156.58, 141.34, 
132.38, 132.22, 128.99, 128.96, 128.72, 128.40, 126.12, 122.33, 121.08, 119.33, 116.85, 
114.18, 112.77, 67.20, 55.27, 45.42, 45.12, 18.16. IR (neat): 3289, 3063, 2961, 2930, 2836, 
1609, 1512, 1465, 1416, 1355, 1303, 1249, 1178, 1034, 999, 912, 815, 746, 676 cm
-1
. 
HRMS (FAB+) calculated for C23H26NO2: 348.1964, observed: 348.1957 (M+H). [α]D
21
 = 
+110 (c 0.5, CHCl3). 
Cinnamylation products 
1-((((1R,2S)-1,2-diphenylbut-3-en-1-yl)amino)methyl)naphthalen-2-ol (3.14): The 
reaction was carried out in DCE according to the general procedure to give 53 mg (73%) of 
the tittle compound. 
1
H NMR (400 MHz, CDCl3) δ 7.75 (dd, J = 8.1, 1.4 Hz, 1H), 7.69 (d, J 
= 8.8 Hz, 1H), 7.66 – 7.53 (m, 1H), 7.36 (ddd, J = 8.5, 6.8, 1.5 Hz, 1H), 7.27 – 7.05 (m, 
10H), 7.01 (dd, J = 6.9, 1.7 Hz, 2H), 6.22 (dt, J = 16.9, 9.7 Hz, 1H), 5.43 – 5.15 (m, 2H), 
4.22 (dd, J = 86.7, 14.3 Hz, 2H), 4.00 (d, J = 9.4 Hz, 1H), 3.66 (t, J = 9.4 Hz, 1H). 
13
C 
NMR (101 MHz, CDCl3) δ 156.57, 140.69, 139.49, 138.93, 138.65, 132.26, 129.18, 128.78, 
128.42, 128.37, 128.12, 128.04, 127.63, 127.32, 126.90, 126.58, 126.25, 122.47, 121.12, 
119.39, 118.21, 117.40, 112.64, 77.40, 77.09, 76.77. IR (neat): 3291, 3061, 3029, 2962, 







.HRMS (FAB+) calculated for C27H26NO: 380.2014, observed: 380.2028 
(M+H) . [α]D
20




H NMR (400 MHz, CDCl3) δ 7.82 – 7.75 (m, 1H), 7.71 (d, J = 9.0 Hz, 1H), 7.61 
(d, J = 8.5 Hz, 1H), 7.46 – 7.34 (m, 2H), 7.33 – 7.25 (m, 2H), 7.20 (ddd, J = 7.6, 6.1, 1.7 
Hz, 2H), 7.17 – 7.10 (m, 2H), 7.01 (ddt, J = 6.7, 4.5, 1.9 Hz, 4H), 6.20 (dt, J = 16.7, 9.8 Hz, 
1H), 5.38 – 5.24 (m, 2H), 4.21 (dd, J = 99.5, 14.2 Hz, 2H), 3.99 (d, J = 9.4 Hz, 1H), 3.61 (t, 
J = 9.5 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 156.39, 140.22, 138.65, 138.26, 132.18, 
132.01, 131.56, 129.68, 129.30, 128.89, 128.81, 128.53, 128.03, 126.80, 126.34, 122.55, 
121.00, 119.32, 118.51, 112.39, 66.78, 57.97, 45.18.IR (neat): 3289, 3061, 3028, 2919, 
2852, 1621, 1597, 1518, 1486, 1467, 1406, 1334, 1269, 1234, 1162, 1072, 1009, 911, 815, 
701 cm
-1
. HRMS (FAB+) calculated for C27H25BrNO: 458.1120, observed: 458.1119 
(M+H). [α]D
21




H NMR (500 MHz, Chloroform-d) δ 7.75 (d, J = 8.1 Hz, 1H), 7.70 (d, J = 8.9 
Hz, 1H), 7.62 (d, J = 8.6 Hz, 1H), 7.40 – 7.33 (m, 1H), 7.28 – 7.25 (m, 1H), 7.21 – 7.08 (m, 
4H), 7.08 – 6.96 (m, 4H), 6.77 (dt, J = 11.0, 2.6 Hz, 2H), 6.31 – 6.10 (m, 1H), 5.39 – 5.19 
(m, 2H), 4.21 (dd, J = 111.3, 14.4 Hz, 2H), 3.96 (d, J = 9.4 Hz, 1H), 3.77 (d, J = 1.1 Hz, 
3H), 3.64 (t, J = 9.4 Hz, 1H). 
13
C NMR (126 MHz, CDCl3) δ 158.89, 156.57, 140.82, 
138.81, 132.25, 131.37, 129.10, 129.06, 128.76, 128.36, 128.13, 126.51, 126.20, 122.42, 





3061, 3029, 3001, 2930, 2909, 2836, 1619, 1512, 1466, 1249, 1177, 1033, 911, 818, 733, 
701 cm
-1
. HRMS (FAB+) calculated for C28H28NO2: 410.2129, observed: 410.2120 (M+H) 
. [α]D
21




H NMR (500 MHz, CDCl3) δ 7.92 – 7.74 (m, 1H), 7.70 (d, J = 8.8 
Hz, 1H), 7.58 (d, J = 8.5 Hz, 1H), 7.50 (d, J = 8.1 Hz, 2H), 7.39 (ddd, J = 8.3, 6.7, 1.3 Hz, 
1H), 7.34 – 7.30 (m, 1H), 7.23 (d, J = 8.1 Hz, 2H), 7.21 – 7.10 (m, 4H), 7.01 – 6.88 (m, 
2H), 6.20 (dt, J = 16.9, 9.7 Hz, 1H), 5.54 – 5.17 (m, 2H), 4.37 (d, J = 14.2 Hz, 1H), 4.22 – 
3.96 (m, 2H), 3.59 (t, J = 9.5 Hz, 1H). 
13
C NMR (126 MHz, CDCl3) δ 156.22, 145.42, 
139.69, 137.74, 132.15, 132.09, 129.47, 128.87, 128.74, 128.66, 128.55, 127.88, 127.03, 
126.42, 122.66, 120.84, 119.22, 119.01, 118.54, 112.17, 111.54, 67.33, 57.96, 45.35. IR 
(neat): 3395, 3292, 3062, 3030, 2916, 2844, 2228, 1622, 1600, 1517, 1468, 1454, 1411, 
1343, 1269, 1234, 1162, 1092, 1000, 911, 817, 733, 701 cm
-1
. HRMS (FAB+) calculated 
for C28H25N2O: 405.1953, observed: 405.1967 (M+H). [α]D
21




H NMR (400 MHz, CDCl3) δ 7.78 – 7.60 (m, 3H), 7.37 (ddd, J = 8.4, 6.8, 1.4 Hz, 
1H), 7.29 – 7.23 (m, 1H), 7.23 – 7.16 (m, 3H), 7.16 – 7.10 (m, 2H), 7.10 – 7.02 (m, 2H), 
6.79 (dd, J = 5.0, 3.5 Hz, 1H), 6.64 (dd, J = 3.5, 1.2 Hz, 1H), 6.18 (dt, J = 17.0, 9.8 Hz, 
1H), 5.38 – 5.22 (m, 2H), 4.45 – 4.13 (m, 3H), 3.64 (t, J = 9.5 Hz, 1H).  13C NMR (126 
MHz, CDCl3) δ 156.38, 143.88, 140.64, 138.41, 132.30, 129.25, 128.79, 128.53, 128.45, 





62.74, 59.03, 45.12. IR (neat): 3291, 3063, 3029, 2968, 2916, 1622, 1599, 1518, 1467, 
1453, 1269, 1233, 1163, 1086, 955, 910, 814, 732, 699 cm
-1
. LRMS (APCI+) calculated for 
C25H23NOS: 385.53, observed: 386.39 (M+H). [α]D
21




H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.1 Hz, 1H), 7.70 (d, J = 8.8 Hz, 1H), 
7.59 (d, J = 8.6 Hz, 1H), 7.37 (t, J = 7.7 Hz, 1H), 7.24 (dt, J = 13.4, 7.2 Hz, 4H), 7.13 (dd, J 
= 15.8, 8.1 Hz, 3H), 6.95 (dd, J = 8.3, 5.4 Hz, 2H), 6.85 (t, J = 8.5 Hz, 2H), 6.19 (dt, J = 
17.0, 9.7 Hz, 1H), 5.48 – 5.17 (m, 2H), 4.22 (dd, J = 107.4, 14.3 Hz, 2H), 3.95 (d, J = 9.5 
Hz, 1H), 3.64 (t, J = 9.5 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ 156.58, 139.39, 138.59, 
136.54, 132.32, 129.65, 129.54, 129.34, 128.90, 128.66, 128.58, 128.07, 127.88, 126.38, 
122.62, 121.19, 119.44, 118.51, 115.45, 115.17, 112.66, 67.46, 57.40, 45.28. IR (neat): 
3292, 3062, 2917, 1621, 1600, 1511, 1229, 1159, 748, 700 cm
-1
. HRMS (FAB+) calculated 
for C27H25FNO: 398.1920, observed: 398.1932 (M+H). [α]D
20





NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.0 Hz, 1H), 7.71 (d, J = 8.8 Hz, 1H), 7.63 (d, J = 
8.7 Hz, 1H), 7.44 – 7.33 (m, 1H), 7.29 – 7.24 (m, 3H), 7.24 – 7.08 (m, 6H), 7.06 – 6.99 (m, 
1H), 6.95 (d, J = 7.6 Hz, 1H), 6.15 (dt, J = 16.8, 9.7 Hz, 1H), 5.41 – 5.19 (m, 2H), 4.37 (d, J 
= 14.4 Hz, 1H), 4.23 – 4.05 (m, 2H), 3.97 (t, J = 9.5 Hz, 1H), 2.10 (s, 3H). 13C NMR (101 
MHz, CDCl3) δ 156.51, 139.61, 139.03, 138.95, 135.60, 132.22, 130.47, 129.16, 128.77, 
128.46, 128.34, 127.86, 127.64, 127.08, 126.23, 125.99, 122.45, 121.10, 119.37, 118.04, 





1453, 1409, 1347, 1268, 1234, 1161, 1089, 1029, 993, 918, 857, 814, 749, 728, 700, 668, 
522, 454. LRMS (APCI+) calculated for C28H27NO: 393.53, observed: 394.46 (M+H). 
[α]D
21
 = +30 (c 0.4, CHCl3). 
1-((((1R,2S)-2-cyclohexyl-1-phenylbut-3-en-1-yl)amino)methyl)naphthalen-2-ol (3.21): 
1
H NMR (500 MHz, CDCl3) δ 7.74 (d, J = 8.0 Hz, 1H), 7.67 (d, J = 8.8 Hz, 1H), 7.60 (d, J 
= 8.5 Hz, 1H), 7.43 (t, J = 7.4 Hz, 2H), 7.40 – 7.32 (m, 4H), 7.27 (dd, J = 12.7, 5.3 Hz, 1H), 
7.12 (d, J = 8.8 Hz, 1H), 5.82 (dt, J = 16.9, 10.0 Hz, 1H), 5.42 – 5.05 (m, 2H), 4.15 (dd, J = 
110.7, 14.3 Hz, 2H), 3.78 (d, J = 9.7 Hz, 1H), 2.39 – 2.21 (m, 1H), 1.85 – 1.49 (m, 5H), 
1.49 – 1.36 (m, 1H), 1.25 – 0.90 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 156.63, 140.93, 
136.87, 132.23, 129.02, 128.83, 128.73, 128.39, 127.85, 127.78, 126.13, 122.33, 121.09, 
119.72, 119.35, 112.77, 63.67, 56.98, 45.08, 37.99, 32.31, 27.54, 26.46, 26.41, 26.36. IR 
(neat): 3294, 3063, 3028, 2923, 2852, 1622, 1599, 1451, 1269, 1232, 1001, 911, 815, 732, 
701 cm
-1
. HRMS (FAB+) calculated for C27H32NO: 386.2470, observed: 386.2484 (M+H) ; 
[α]D
21




H NMR (500 MHz, CDCl3) δ 7.76 (d, J = 8.0 Hz, 1H), 7.71 (d, J = 8.8 Hz, 1H), 
7.60 (d, J = 8.6 Hz, 1H), 7.38 (dd, J = 22.1, 8.0 Hz, 2H), 7.28 – 7.18 (m, 8H), 7.15 (d, J = 
8.8 Hz, 1H), 7.00 – 6.92 (m, 1H), 6.13 (dt, J = 17.0, 9.6 Hz, 1H), 5.52 – 5.16 (m, 2H), 4.39 
(t, J = 9.3 Hz, 1H), 4.30 (d, J = 14.3 Hz, 1H), 4.17 – 4.09 (m, 2H). 13C NMR (126 MHz, 
CDCl3) δ 156.51, 139.99, 139.02, 137.46, 133.14, 132.23, 129.20, 129.15, 128.76, 128.41, 





112.56, 66.20, 55.11, 45.02. IR (neat): 3290, 3061, 3029, 2920, 2851, 1621, 1598, 1468, 
1235, 1021, 911, 749, 730, 700 cm
-1
. HRMS (FAB+) calculated for C27H25BrNO: 458.1117, 
observed: 458.1120 (M+). [α]D
21




H NMR (400 MHz, CDCl3) δ 8.28 – 8.01 (m, 1H), 7.81 – 7.63 (m, 2H), 7.63 – 
7.46 (m, 2H), 7.43 – 7.32 (m, 2H), 7.28 – 7.18 (m, 5H), 7.19 – 7.09 (m, 2H), 6.13 (dt, J = 
17.1, 9.6 Hz, 1H), 5.51 – 5.09 (m, 2H), 4.38 – 3.94 (m, 4H). 13C NMR (126 MHz, CDCl3) δ 
156.42, 150.78, 149.08, 147.54, 138.67, 137.89, 136.33, 135.28, 132.23, 129.33, 128.78, 
128.75, 128.16, 127.73, 126.28, 122.53, 122.40, 121.07, 120.03, 119.26, 112.41, 65.52, 
52.99, 44.85. IR (neat): 3287, 3060, 3028, 2920, 2851, 1622, 1598, 1581, 1563, 1516, 1467, 
1453, 1406, 1270, 1234, 1061, 911, 814, 732, 748, 701 cm
-1
. HRMS (FAB+) calculated for 
C26H24ClN2O: 415.1593, observed: 415.1577 (M+H). [α]D
21
 = +69 (c 0.8, CHCl3).
 
Cleavage Products 
tert-butyl ((1R,2R)-2-methyl-1-phenylbut-3-en-1-yl)carbamate (3.31a): 
1
H NMR (400 
MHz, CDCl3) δ 7.38 – 7.28 (m, 2H), 7.25 – 7.18 (m, 3H), 5.71 (ddd, J = 16.5, 11.0, 7.3 Hz, 
1H), 5.29 – 4.92 (m, 2H), 4.86 (s, 1H), 4.50 (s, 1H), 2.52 (s, 1H), 1.38 (s, 9H), 0.98 (d, J = 
6.8 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 155.40, 139.57, 128.27, 126.97, 126.70, 
116.10, 79.38, 58.92, 43.70, 28.33, 17.04. IR (neat): 3384, 3063, 3032, 2978, 2928, 1679, 
1516, 1170, 701, 523 cm
-1
. HRMS (FAB+) calculated for C16H24NO2: 262.1807, observed: 
262.1799. (M+H). [α]D
20





tert-butyl ((1R,2R)-1-(4-bromophenyl)-2-methylbut-3-en-1-yl)carbamate (3.31b): 
1
H 
NMR (400 MHz, CDCl3) δ 7.44 (d, J = 8.4 Hz, 2H), 7.11 (d, J = 8.4 Hz, 2H), 5.67 (ddd, J = 
17.1, 10.5, 7.3 Hz, 1H), 5.25 – 5.00 (m, 2H), 4.84 (s, 1H), 4.43 (s, 1H), 2.47 (d, J = 11.2 Hz, 
1H), 1.38 (s, 9H), 0.98 (d, J = 6.8 Hz, 3H). 
13
C NMR (101 MHz, CDCl3) δ 155.28, 139.08, 
131.37, 128.44, 120.76, 116.58, 99.99, 79.64, 58.53, 43.48, 28.31, 16.98. IR (neat): 3376, 
2985, 2968, 2931, 1680, 1518, 1165, 1008, 820, 602, 525 cm
-1
. HRMS (FAB+) calculated 
for C16H23BrNO2: 340.0912, observed: 340.0912 (M+H). [α]D
20
 = +41 (c 0.95, CHCl3). 
tert-butyl ((1R,2S)-1,2-diphenylbut-3-en-1-yl)carbamate (3.32): 
1
H NMR (400 MHz, 
CDCl3) δ 7.40 – 7.22 (m, 3H), 7.23 – 7.10 (m, 4H), 7.09 – 6.87 (m, 3H), 6.28 – 5.95 (m, 
1H), 5.32 – 5.08 (m, 2H), 4.99 (s, 1H), 4.93 (s, 1H), 3.56 (t, J = 8.5 Hz, 1H), 1.40 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 155.18, 140.48, 138.30, 128.37, 128.31, 128.01, 127.06, 
126.63, 126.23, 126.17, 117.43, 79.59, 58.97, 57.14, 28.34. IR (neat): 3401, 3032, 2979, 
1684, 1513, 1248, 1170, 756, 698 cm
-1
. HRMS (FAB+) calculated for C21H26NO2: 
324.1964, observed: 324.1972 (M+H). [α]D
21
 = +6.2 (c 0.80, CHCl3). 
tert-butyl ((1R,2S)-1-(4-methoxyphenyl)-2-phenylbut-3-en-1-yl)carbamate (3.33): 
1
H 
NMR (500 MHz, CDCl3) δ 7.22 – 7.19 (m, 2H), 7.18 – 7.12 (m, 1H), 7.09 – 7.00 (m, 2H), 
7.00 – 6.93 (m, 2H), 6.81 – 6.68 (m, 2H), 6.13 (ddd, J = 17.1, 10.4, 8.9 Hz, 1H), 5.27 – 5.09 
(m, 2H), 4.93 (s, 2H), 3.76 (s, 3H), 3.57 (t, J = 8.7 Hz, 1H), 1.43 (s, 9H). 
13
C NMR (126 
MHz, CDCl3) δ 158.46, 155.15, 140.59, 138.56, 128.41, 128.29, 128.12, 127.37, 126.56, 





1237, 1164, 1014, 918, 756, 556 cm
-1
. HRMS (FAB+) calculated for C22H28NO3: 354.2069, 
observed: 354.2084 (M+1). [α]D
21
 = +5.0 (c 0.43, CHCl3). 
tert-butyl ((1R,2S)-2-(4-fluorophenyl)-1-phenylbut-3-en-1-yl)carbamate  (3.34): 
1
H 
NMR (500 MHz, CDCl3) δ 7.25 – 7.15 (m, 3H), 7.07 – 7.02 (m, 2H), 7.01 – 6.95 (m, 2H), 
6.90 (t, J = 8.7 Hz, 2H), 6.12 (ddd, J = 17.0, 10.1, 8.6 Hz, 1H), 5.31 – 5.09 (m, 2H), 4.99 (s, 
1H), 4.91 (s, 1H), 3.59 (t, J = 8.6 Hz, 1H), 1.42 (s, 9H).
13
C NMR (101 MHz, CDCl3) 
13
C 
NMR (126 MHz, CDCl3) δ 162.51, 160.56, 155.13, 140.73, 138.09, 136.26, 131.88, 129.81, 
129.74, 128.59, 128.12, 127.64, 127.57, 127.26, 127.12, 127.01, 126.24, 125.37, 117.56, 
115.45, 115.27, 115.20, 115.04, 79.66, 58.97, 56.29, 28.33 (Not 
19
F decoupled). IR (neat): 
3384, 3033, 3006, 2978, 2933, 1687, 1505, 1159, 701, 521 cm
-1
. HRMS (FAB+) calculated 
for C21H25FNO2: 342.1869, observed: 342.1875 (M+1). [α]D
21
 = +12 (c 0.95, CHCl3). 
tert-butyl ((1R,2S)-2-cyclohexyl-1-phenylbut-3-en-1-yl)carbamate (3.35): 
1
H NMR (400 
MHz, CDCl3) δ 7.34 (dd, J = 8.6, 6.6 Hz, 2H), 7.25 (dd, J = 7.9, 5.9 Hz, 3H), 5.68 (dt, J = 
17.0, 10.0 Hz, 1H), 5.17 (dd, J = 10.2, 2.0 Hz, 1H), 4.96 (dd, J = 17.1, 2.0 Hz, 1H), 4.86 (d, 
J = 7.7 Hz, 1H), 4.78 (s, 1H), 2.22 – 2.05 (m, 1H), 1.82 (d, J = 11.3 Hz, 1H), 1.70 (m, 2H), 
1.61 (m, 2H), 1.40 (s, 9H), 1.24 – 1.04 (m, 5H), 1.04 – 0.91 (m, 1H). 13C NMR (101 MHz, 
CDCl3) δ 155.28, 136.44, 128.28, 126.87, 126.77, 118.61, 79.31, 56.53, 37.69, 31.96, 
28.54, 28.34, 27.69, 26.50, 26.42, 26.38. IR (neat): 3425, 3068, 2975, 2931, 2853, 1692, 
1505, 1168, 702 cm
-1
. HRMS (FAB+) calculated for C21H32NO2: 330.2433, observed: 
330.2418 (M+1). [α]D
21






tert-butyl ((1R,2S)-2-(2-chloropyridin-3-yl)-1-phenylbut-3-en-1-yl)carbamate (3.36): 
1
H NMR (400 MHz, CDCl3) δ 8.37 – 8.10 (m, 1H), 7.62 (dd, J = 7.8, 1.9 Hz, 1H), 7.27 – 
7.24 (m, 3H), 7.24 – 7.10 (m, 4H), 6.06 (ddd, J = 17.0, 10.2, 8.2 Hz, 1H), 5.26 (dt, J = 10.2, 
1.0 Hz, 1H), 5.18 (d, J = 17.0 Hz, 1H), 5.10 (d, J = 8.5 Hz, 1H), 5.03 (d, J = 9.0 Hz, 1H), 
4.28 (t, J = 8.2 Hz, 1H), 1.41 (s, 9H).
 13
C NMR (101 MHz, CDCl3) δ 155.08, 151.11, 
147.61, 140.03, 137.95, 135.94, 135.32, 128.49, 127.55, 126.80, 122.43, 119.02, 79.89, 
57.68, 51.87, 28.29. IR (neat): 3277, 2978, 2930, 1697, 1165, 753, 701 cm
-1
. HRMS 
(FAB+) calculated for C20H24ClN2O2: 359.1526, observed: 359.1521 (M+1). [α]D
21












Bi(OTf)3 – PyBox Catalyzed Asymmetric Allylation of Aldehydes via Strained Silanes 
4.1. Introduction 
In a similar manner that the asymmetric allylation of the imino group is important 
for the synthesis of chiral amines, the asymmetric allylation of aldehydes is one the most 
valuable transformation for the synthesis of chiral alcohol building blocks. A substantial 
amount of literature precedent on stoichiometric and catalytic systems developed for this 
chemical reaction has been reported.
1
 Here at Columbia University, the Leighton group has 
largely made its contribution to this field inspired on the idea of methodology efficacy, 
efficiency, and scalability. In doing so, the Leighton group has developed several methods 
for the allylation and crotylation of aldehydes and ketones
2
 by utilizing readily and 
inexpensively synthesized strained silane Lewis acids (Figure 4-1). 






 Unlike the imino group, in which a protic nucleophile (XH) is required as an 
activating group to boost its reactivity with the Leighton strained silane reagents, aldehydes 
typically do not require this extra feature. Mainly, this is due to the fact that they are 
inherently more electrophilic and less hindered than N-substituted imines; therefore, the 
silacycle strain release is sufficient to drive reactivity (Figure 4-1, Case I and Figure 4-2).  
Figure 4-2: Imines vs. Aldehyde Allylation with Strained Silanes 
 
 While aldehydes are the simplest and most reactive carbonyl species towards 
asymmetric allylation, ketones are much harder to allylate given that they are typically less 
electrophilic and more sterically hindered (Figure 4-1, Cases II and III). However, invoking 
the concept of activating groups as exemplified in imine allylations, the Leighton group has 
demonstrated a powerful approach to the asymmetric allylation of phenolic ketones
3
 and β-
diketones which are substrates that inherently contain a protic nucleophile as an activating 
group: the phenolic and the enol oxygens, respectively
4
 (Figure 4-3). These reactions have 






Figure 4-3: Generic Allylation of Phenolic Ketones and β-Diketones 
 
On the other hand, there are cases in which stubborn aldehyde substrates do not 
perform well in the Leighton allylation protocols given that they are severely hindered. For 
these aldehydes, the Leighton group has shown that catalytic amounts of an external Lewis 
acid, such as scandium (III) triflate, can dramatically accelerate the rate of allylation and 
crotylation reactions of standard to sterically congested aldehydes with chiral diamine-
derived allylsilane reagents 4.2
5
. This combination is also commercially known as the EZ 
allyl and crotyl mixes for allylation and crotylation, respectively (Figure 4-4).  






 The role of scandium triflate in this methodology is thought to be analogous to that 
of the protic nucleophile available in imine activating groups. In imines, this protic 
nucleophile displaces the chloride of the reagent, generating one equivalent of HCl, which 
protonates the nitrogen adjacent to silicon; thus, decreasing its electron density and 
enhancing its Lewis acidity (Figure 4-2). In the case of scandium triflate, it can be 
envisioned that coordination with one of the nitrogens adjacent to the silicon will cause the 
same effect (Figure 4-5).  
Figure 4-5: Sc(OTf)3 Catalyzed Asymmetric Allylation of Aldehydes 
 
 While all the previous methodologies reported have so far proved to be effective, 
efficient, and convenient, we wanted to further explore the catalysis avenue for the 
asymmetric allylation of aldehydes so that the use of stoichiometric chiral reagents could be 
avoided. Unlike silanes 4.1, for which optically pure pseudoephedrine precursor can be 
inexpensively purchased in kilo amounts, the diamine precursor to the EZ-allyl and EZ-
crotyl mixes requires a chiral resolution to reduce cost and achieve high optical purity plus 
a synthetic step. We envisioned that if instead an achiral strained silane 4.4 could be both 
activated and chirally differentiated by external catalytic amounts of either a chiral Brønsted 
acid
6
, hydrogen-bond donor, or Lewis acid
7
 species Z*, the enantioselective allylation of 





Figure 4-6: Proposed Catalytic Asymmetric Allylation of Aldehydes 
 
4.2. Initial Catalytic Design: Brønsted Acids as Possible Catalysts  
 With the idea of using achiral silanes as reagents in mind, we promptly synthesized 
allyl chlorosilanes derived from several commercially available achiral diols and diamines 
in order to study their background reactivity with aldehydes in the absence of added 
catalysts (Scheme 4-1).  
Scheme 4-1: Synthesis of Achiral Chlorosilane Reagents 
 
 The reactivity of silanes 4.4, 4.7, and 4.8 towards benzaldehyde was indeed already 
precedented in our group. Silanes 4.7 and 4.8 were inactive even at 50
o
C with the exception 
of silane 4.4 which was active at room temperature albeit at high concentration (1.0M). 





of aldehydes within the Leighton group since it represents a proof of concept for silicon 
strain release Lewis acidity in the oxasilacyclopentane series
8
. This seminal discovery led to 
the development of all of our chiral silane reagents. In agreement with that discovery, we 
also found that silanes 4.5 and 4.6 were also active and even more reactive as they fully 
converted benzaldehyde to its homoallylic alcohol at room temperature and at more dilute 
concentrations.    
 Next, we subjected benzaldehyde and hydrocinnamaldehyde to these silanes in 
presence of catalytic amounts of chiral Brønsted acids as potential catalysts
9
 (Table 4-1). 
Based on the results on this table, we noticed that systems in which there was no 
background reaction (entries 1, 8, and 14), addition of the Brønsted acids did not afford any 
conversion to desired product. Conversely, systems with active background reactions 
(entries 5 and 11), addition of Brønsted acids did not improve the reaction rate or gave any 
enantioselectivity even at lower reaction temperatures (entries 6 and 7). Moreover, attempts 
to suppress the rate of the background reaction by introducing a hindered aldehyde only 












Table 4-1: Screen of Silanes and Added Chiral Catalysts  
 
Entry R Silane Catalyst T Time Observations 
1 Ph 4.4 no catalyst rt > 24 h no reaction 
2 Ph 4.4 10 mol% A, R’ = H rt > 24 h no reaction 
3 Ph 4.4 10 mol% A, R’ = H 45°C > 24 h no reaction 
4 Ph 4.4 10 mol% B rt > 24 h no reaction 
5 Ph 4.5 no catalyst rt 2 h 100% conversion 
6 Ph 4.5 10 mol% A, R’ = H -10°C > 24 h 74%, 0% ee 
7 Ph 4.5 10 mol% B -10°C > 24 h 74%, 0% ee 
8 (E)-PhCHC(CH3) 4.5 no catalyst rt >   8 h no reaction 
9 (E)-PhCHC(CH3) 4.5 10 mol% A, R’ = H rt > 16 h no reaction 
10 (E)-PhCHC(CH3) 4.5 10 mol% B rt > 24 h no reaction 
11 Ph 4.6 no catalyst rt 4 h **** 
12 Ph 4.6 10 mol% A, R’ = H rt 4 h 11%, 0% ee 
13 Ph 4.6 10 mol% B rt 4 h 38%, 0% ee 
14 Ph 4.8 no catalyst rt > 24 h no reaction 
15 Ph 4.8 10 mol% A, R’ = H rt > 24 h no reaction 
16 Ph 4.8 10 mol% A, R’ = 3,5-CF3Ph rt > 24 h no reaction 
17 Ph 4.8 10 mol% A, R’ = 3,5-CF3Ph reflux 12 h decomposition 
 
4.3. Initial Catalytic Design: Chiral Lewis Acids as Potential Catalysts 
 We turned our attention to studying the effect of chiral Lewis acid complexes to the 
allylation systems reported above
10
. We initially chose scandium triflate as the Lewis acid 
since it has been shown to enhance the rate of aldehyde allylation with chiral diamine-





pyridinebisoxazoline ligands (PyBOX) complexes are well precedented as Lewis acid 
catalysts in several asymmetric transformations
11
 (Table 4-2).  
 Recalling that silane 4.4 does not display uncatalyzed background reactions with 
benzaldehyde or hydrocinnamaldehyde at 0.1M, the data collected on Table 4-2 reveals that 
only this silane is participating in the allylation catalysis by uncomplexed Sc(OTf)3 (Entries 
1 and 7). When Sc(OTf)3 is complexed with chiral PyBOX ligands; however, the allylation 
is shut down for both aldehydes, in different solvents, at room temperature and at 45°C 
(entries 1-8). Silanes 4.5 and 4.6 had displayed uncatalyzed background allylation reactions 
with benzaldehyde at room temperature, so we attempted to cool down the reaction to -
10°C when adding complexed Sc(OTf)3 to see if we could obtain any enantioselectivity. 
While the yields were good, the reactions underwent a completely racemic pathway (entries 
9-13). One possible explanation is that the complexed Sc(OTf)3 loses catalytic activity with 
our silanes, as observed with silane 4.4, allowing the racemic background allylation 
reaction of benzaldehyde and 4.5 and/or 4.6 to proceed. Conversely, silanes 4.7 and 4.8 do 
not display any reactivity with benzaldehyde or hydrocinnamaldehyde with or without any 
catalyst added even at higher temperatures. This is probably due to the fact that these 
silanes are not as strained as the five member ring silacycles; thus, they are inherently less 









Table 4-2: Effect of Sc(OTf)3·PyBOX Complexes 
 
Entry R Silane Catalyst T Solvent Time Observations 
1 Ph 4.4 10 mol% Sc(OTf)3 rt CDCl3 1 h 50% conversion 
2 Ph 4.4 
10 mol% Sc(OTf)3 
10 mol% (R)-iPrPyBOX 
rt CDCl3 > 24 h no reaction 
3 Ph 4.4 
10 mol% Sc(OTf)3 
10 mol% (R)-iPrPyBOX 
45°C CDCl3 > 24 h no reaction 
4 Ph 4.4 
10 mol% Sc(OTf)3 
10 mol% (R)-iPrPyBOX 
rt Toluene > 24 h no reaction 
5 Ph 4.4 
10 mol% Sc(OTf)3 
10 mol% (R)-iPrPyBOX 
45°C Toluene > 24 h no reaction 
6 Ph 4.4 
10 mol% Sc(OTf)3 
10 mol% (R)-PhPyBOX 
rt CDCl3 > 24 h no reaction 
7 PhCH2CH2 4.4 10 mol% Sc(OTf)3 rt CDCl3 3 h 100% conversion 
8 PhCH2CH2 4.4 
10 mol% Sc(OTf)3 
10 mol% (R)-iPrPyBOX 
rt CDCl3 > 24 h no reaction 
9 Ph 4.5 10 mol% Sc(OTf)3 rt CDCl3 2 h 100% conversion 
10 Ph 4.5 
10 mol% Sc(OTf)3 
10 mol% (R)-PhPyBOX 
rt CDCl3 2 h 100%, 0% ee 
11 Ph 4.5 
10 mol% Sc(OTf)3 
10 mol% (R)-PhPyBOX 
-10°C CDCl3 1 h 89%, 0% ee 
12 Ph 4.6 10 mol% Sc(OTf)3 rt CDCl3 2 h 100% conversion 
13 Ph 4.6 
10 mol% Sc(OTf)3 
10 mol% (R)-PhPyBOX 
rt CDCl3 2 h 93%, 0% ee 
14 (E)-PhCHC(CH)3 4.6 10 mol% Sc(OTf)3 rt CDCl3 > 24 h no reaction 
15 Ph 4.7 10 mol% Sc(OTf)3 rt CDCl3 > 24 h no reaction 
16 Ph 4.7 10 mol% Sc(OTf)3 45°C CDCl3 > 24 h no reaction 
17 PhCH2CH2 4.7 10 mol% Sc(OTf)3 rt CDCl3 > 24 h no reaction 
18 PhCH2CH2 4.7 10 mol% Sc(OTf)3 45°C CDCl3 > 24 h no reaction 
19 Ph 4.8 10 mol% Sc(OTf)3 rt CDCl3 > 24 h no reaction 
20 Ph 4.8 
10 mol% Sc(OTf)3 
10 mol% (R)-iPrPyBOX 








4.4. Changing Strategy: Modifying Silane Structure and Electronics 
 While we could continue screening for different backbones on allyltrichlorosilane 
and/or chiral Lewis acids, we decided instead to derivatize the pinacol-derived silane 4.4 
since this silane showed rate acceleration and reaction completion with benzaldehyde when 
Sc(OTf)3 was added. In addition, the Leighton group had previously shown that when 
benzaldehyde is subjected to allyl siloxane 4.9, it undergoes a tandem aldol – allylation 
reaction to give diol 4.10 and a minor allylation product 4.11
12
 (Scheme 4-2).  
Scheme 4-2: The Leighton Tandem Aldol – Allylation Reaction 
 
 Interestingly, when catalytic amounts of Sc(OTf)3 were added to the above reaction, 
overall rate acceleration was observed along with an increased ratio of direct allylation 
product 4.11 to tandem product 4.10
13
. Presumably, this is due to coordination of the silyl 
enol ether oxygen to Sc(OTf)3, which could decrease its inherent nucleophilicity to effect 
the aldol reaction; therefore, allowing direct allylation to occur more facile (Scheme 4-3). 






 While this observation was perhaps detrimental for the purposes of the tandem 
aldol-allylation methodology, it served as a model to redesign our catalytic system. For 
simplicity, we substituted the chloride in 4.4 with a methoxy group. This transformation 
was easily achieved by stirring 4.4 with DBU and methanol from 0°C to room temperature 
to obtain 4.12 in 74% yield
14
 (Scheme 4-4).  
Scheme 4-4: Preparation of 1-allyl-1-methoxy-1,1’-pinacol silane 
 
 With silane 4.12 in hand, we tested its performance in allylation reactions with 
benzaldehyde in presence of the previously discussed Brønsted acids and Lewis acid 
catalysts (Table 4-3). 
Table 4-3: Probing the Reactivity of Allylsiloxane 
 
Entry Catalyst 
1 no catalyst 
2 10 mol% A, R = H* 
3 10 mol% Bi* 
4 10 mol% Sc(OTf)3 
5 
10 mol% Sc(OTf)3 
15 mol% (R)-PhPyBOX 
* Refer to Table 4-1 catalysts 
  
 While the results presented on Table 4-3 were not encouraging, we decided to 





by going from 4.4 to 4.12, and hard and soft acid-base interactions could play an important 
role. We chose among several metal triflates to perform the screen: Sc(OTf)3, In(OTf)3, 
La(OTf)3, Bi(OTf)3, Y(OTf)3, Yb(OTf)3, Zn(OTf)2, and Cu(OTf)2. We were glad to find out 
that both indium (III) triflate and bismuth (III) triflate were able to catalyze the allylation of 
benzaldehyde with 4.12 at room temperature while the other metal triflates were virtually 
inert to the reaction conditions. With these findings, we complexed both In(OTf)3 and 
Bi(OTf)3 to commercially available chiral BOX and PyBOX ligands and used these 
complexes as chiral Lewis acid catalysts (Table 4-4). 
Table 4-4: Chiral In(OTf)3/Bi(OTf)3 – BOX/PyBOX Complexes as Catalysts 
 
Entry Catalyst % Yield, % ee Observations 
1 
10 mol% In(OTf)3 
15 mol% A 
no reaction --- 
2 
10 mol% In(OTf)3 
15 mol% B 
no reaction --- 
3 
10 mol% In(OTf)3 
15 mol% C 
no reaction --- 
4 
10 mol% Bi(OTf)3 
15 mol% A 
75%, 16% ee --- 
5 
10 mol% Bi(OTf)3 
15 mol% B 
84%, 0% ee --- 
6 
10 mol% Bi(OTf)3 
15 mol% C 
96%, 46% ee --- 
7 
10 mol% Bi(OTf)3 
15 mol% C 
15%*, 68% ee with 4 ÅMS 
8 
10 mol% Bi(OTf)3 
15 mol% C 
20%*, 9% ee 
with 50 mol% 
iPr2NEt 
9 
10 mol% Bi(OTf)3 
15 mol% C 
100%*, 35% ee 1 h complexation 
10 
10 mol% Bi(OTf)3 
15 mol% C 






 While we found that In(OTf)3 complexes with either BOX or PyBOX ligands were 
not active catalysts (Entries 1-3), we were glad to discover that Bi(OTf)3 complexes do 
catalyze the allylation of benzaldehyde. Among the three ligands tested, (R)-PhPyBOX 
gave the best results in terms of yield (96%) and enantioselectivity (46% ee) for the 
corresponding homoallylic alcohol 4.13 (Table 4-4, Entry 6). We screened a few additional 
conditions with the same ligand in order to study their impact on catalysis and selectivity. 
We found that by running the reaction with activated molecular sieves, or adding Hunig’s 
base as a scavenger for adventitious acid, or doubling the time of the metal – ligand 
complexation did not improve the originally obtained results. We also applied our best 
conditions (Entry 6) using silane 4.4, but we found that while the reaction is in fact 
catalyzed, we observed no enantioselectivity. Presumably, this is an indication that the 
methoxy oxygen on silane 4.12 does not only play an important role for reactivity, but also 
for enantioselectivity. 
4.5. Bi(OTf)3·PyBOX Catalyzed Asymmetric Allylation of Aldehydes 
 With goals now set on reaction optimization, we screened several other PyBOX 
ligands under our best behaved conditions (Table 4-5). The best enantioselectivities for 
benzaldehyde allylation were observed when using chiral phenethyl PyBox B and 
IndaPyBOX D (Entries 2 and 4). Using chiral PyBox C resulted in lower enantioselectivity 
and much slower reactions times (Entry 3). Finally, using chiral PyBOX A completely shut 
down the reaction. Based on the results from Tables 4-4 and 4-5, it seems like the reaction 
rate is sensitive to the ligand’s denticity and steric bulk since the larger these two 





drastically affect the reaction selectivity since bidentate BOX ligands gave much lower 
selectivities than the tridentate PyBOX ligands. This might be partly due to further 
projection of the chiral groups from the ligand towards the metal center and tighter binding 
of the bismuth as the ligand denticity increases. 
Table 4-5: PyBOX Ligand Screen 
 
Entry Catalyst % ee 
1 
10 mol% Bi(OTf)3 




10 mol% Bi(OTf)3 
15 mol% B 
89.5% ee 
3 
10 mol% Bi(OTf)3 
15 mol% C 
29% ee 
4 
10 mol% Bi(OTf)3 
15 mol% D 
92% ee 
 
 Given that the IndaPyBOX ligand provided the best selectivity, we proceeded to 
screen solvents for continuing our reaction optimization. We found that dichloromethane 





asymmetric allylation of benzaldehyde (Scheme 4-5). The reactions were run at room 
temperature and took 48 hours for full conversion.  
 
Scheme 4-5: Optimized Catalytic Asymmetric Allylation of Benzaldehyde 
 
 In order to further explore the catalytic power of our chiral Bi(OTf)3·IndaPyBOX 
complex, we attempted to lower the catalyst loading. However, this just led to much longer 
reaction times (»48 hours). In addition, attempts to speed the rate of the reaction by heating 
led to complete shutdown of the reaction. This is presumably due to catalyst 
decomposition
15
 or change in its coordination state to an inactive species since the starting 
materials remain intact. Finally, attempts to speed the reaction rate by increasing the 
concentration of the starting materials only resulted in lower enantioselectivities and 
variable reaction times. While we tried to study the reaction behavior over time by 
1
H NMR 
at higher concentrations, the spectral analysis became much more complicated as other 
unidentifiable species besides starting materials and product were observed.  
 In order to explore the performance of other aldehydes in the protocol shown in 
Scheme 2-3, we subjected hydrocinnamaldehyde and trans-α-methylcinnamaldehyde as 
representative examples of aliphatic and hindered substrates, respectively (Table 4-6). We 





homoallylic alcohols in excellent enantioselectivity albeit in moderate yield in the case of 
trans-α-methylcinnamaldehyde. However, this comes as no surprise since this aldehyde has 




Table 4-6: Substrate Scope of the Bi(OTf)3·IndaPyBOX Catalyzed Allylation 
 
4.6. Experimental Challenges 
 After studying the substrates shown in Table 4-6, we wanted to test the silane’s 
performance with more synthetically valuable aldehydes such as chiral β-silyloxy and β-
alkoxy aldehydes. With the former types of aldehydes, we found that reaction progress was 
similar to the previously shown substrates, but regardless of silyl group size and stability 





methoxybenzyl aldehydes proved incompatible with our allylation conditions as major 
decomposition was observed, presumably because of the Lewis acidic bismuth species 
and/or silane
17. Moreover, with the β-benzyloxy-derived Roche aldehyde, we observed 
lower reaction yields and low diastereoselectivities (Scheme 4-6).  
Scheme 4-6: Allylation of β-benzyloxy Chiral Aldehyde
 
 We originally thought that we had perhaps reached within the limits of our 
methodology given that chiral aldehydes of this sort are well behaved substrates with chiral 
diamine-derived strained allylsilanes. For control purposes, we decided to test the reagent 
and catalyst quality, so we attempted to reproduce the allylation of benzaldehyde with our 
current method, and we observed significant erosion of enantioselectivity (45% ee 
compared to 92% ee initially reported). Given that triflic acid does catalyze the allylation of 
benzaldehyde with silane 4.12, we suspected that trace amounts of the acid were 
responsible for activating a racemic pathway for the reaction; thus, resulting in erosion of 
enantioselectivity. In order to test this hypothesis, we added 5 mol% of 2,6-ditert-butyl-4-
methyl pyridine as  part of the complexation stage of Bi(OTf)3 and (S,R)-IndaPyBOX, and 
we were glad to find out that the enantioselectivity was even higher than initially reported  





conditions and also at twice the scale and at twice the concentration, separately. While we 
were glad to find a way to circumvent the racemic pathway triggered by triflic acid, we also 
found that the rate of the reaction was significantly depressed by its absence. For instance, 
conversions of 20% were observed at 48 hours with the base additive versus 100% 
conversion at the same reaction time without it, suggesting that small amounts of acid also 
play an important role in the reaction rate. At first sight, these observations lead us to 
believe that perhaps with quantitatively controlled amounts of acid, we could find a balance 
between the reaction rate and enantioselectivity. This could be a possible explanation for 
the original high yielding and enantioselective results observed in Table 4-6 where no base 
additives were used. However, given that we initially used 5 mol% of the base additive, 
which is already half of the Bi(OTf)3 loading in the reaction, we envisaged that any excess 
base remaining after scavenging the partially hydrolyzed Bi(OTf)3 could be responsible of 
inhibiting the unhydrolized Bi(OTf)3 ability to generate the active chiral complex catalyst 
with the PyBOX ligand. In order to test this hypothesis, we treated the Bi(OTf)3•PyBOX 
mixture with different loadings of the base additive (Table 4-7). We found that when lower 
base loading (3 mol%) was used, the reaction proceeded relatively faster and with equally 
high enantioselectivity. Conversely, when higher loading (15 mol%) of the base was used, 
the reaction was significantly slower yet still highly enantioselective. These experimental 
results reconfirmed our hypothesis that triflic acid was the cause of enantioselectivity 
erosion as it can catalyze the racemic background allylation reaction.  Moreover, these 
results also confirm that there is indeed a negative effect towards active catalyst formation 





butyl-4-methylpyridine is known to be very sterically hindered and just capable of 
accepting a proton
18
, we believe that such negative effect that this base poses in our 
chemistry is due to its binding to Bi(OTf)3, which inhibits the formation of the chiral active 
catalyst. This binding seems to be slowly reversible since the reaction still proceeds even in 
excess of the base additive relative to the total loading of Bi(OTf)3. Other alternatives to 
circumvent the rate depression problem could involve exploring other basic and non-
nucleophilic systems, and/or increasing the concentration of the reaction, and/or further 
modifying silane structure and electronics to render it more Lewis acidic. Future work for 
further optimization of this procedure should definitely be the focus of this project. 
Table 4-7: Effect of 2,6-ditert-butyl-4-methylpyridine 
 
4.7. Mechanistic Insights  
 Having shown the proof of concept that external chiral Lewis acids can catalyze 





how the reaction works. In particular, we were interested in the role of the methoxy group 
in silane 4.12 and its presumed coordination with the chiral Lewis acid species as it was 
hypothesized in the Tandem aldol-allylation case with Sc(OTf)3. In order to do this, we 
changed a few features of the silane. We synthesized silanes 4.14 and 4.15 and subjected 
them to the reaction conditions in Table 4-5. We found out that the reactions with these 
silanes proceeded much more slowly and were also much less selective than with silane 
4.12 (Scheme 4-7).  
Scheme 4-7: Comparison of Rate and Selectivity between Silanes 
 
 The silanes shown in scheme 4-7 do not exhibit racemic background allylation 
reactions with benzaldehyde under the conditions shown. The fact that these reactions even 
occur with addition of the chiral Lewis acid complex is highly suggestive that one of the 
oxygens in the pinacol backbone is involved in coordination with the chiral Lewis acid for 
activation. While one could claim that the chiral Lewis acid is activating the aldehyde for 
allyl transfer in a Sakurai Type II allylation reaction
19
, the siloxanes shown above are not 





the slower reaction rates observed in absence of the methoxy substituent could be indicative 
that this group might also be involved in the transition state by coordinating to the chiral 
Lewis acid. It is noteworthy to point out that when the methoxy group is changed to 
isopropoxy in silane 4.17, the reaction barely gives any conversion, which could be 
attributed to the inability of the alkoxy oxygens to bind the Lewis acid due of sterics. 
Moreover, since the reactions also display a drop in enantioselectivity, it could further 
suggest that the methoxy group participates in the enantio-determining step, providing a 
more highly organized transition state. These observations are consistent with that of the 
effect of scandium triflate in the tandem aldol-allylation of aldehydes presented in section 
4.4 and in the crotylation of aldehydes with chiral diamine-derived allylsilanes referred to in 
section 4.1.  
4.8. Conclusions 
 We have developed a catalytic enantioselective approach to the asymmetric 
allylation of aldehydes using chiral Bi(OTf)3·PyBOX in combination with achiral strained 
allyl silane reagents. Representative allylation examples of aromatic, aliphatic, and hindered 
aldehydes have been demonstrated in this methodology, affording the corresponding 
homoallylic alcohols in good yields and high enantioselectivities. Progress remains to be 
done to better understand the mechanism of this reaction so that its full potential can be 
exploited. In doing so, one could more efficiently expand the substrate scope to more 
elaborate and synthetically valuable aldehydes.  This method is by far, to the best of our 
knowledge, the first reported Lewis acid-catalyzed allylation of aldehydes using achiral 
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4.10. Experimental Section 
All reactions were carried out in flame-dried glassware under an inert atmosphere of 
nitrogen with magnetic stirring unless otherwise indicated. Methylene chloride and toluene 
were obtained from Fisher and purified by degassing with argon followed by passage 
through an activated neutral alumina column. Triethylamine was purchased from Alfa 
Aesar and purified by distillation from CaH2 then stored under nitrogen. Pentane (HPLC 
grade) was purchased from Fisher and used as received. Anhydrous chloroform (stabilized 
with amylenes) and 1,2-dichloroethane were purchased from Aldrich and used as received. 
Aldehydes and all other reagents were purchased from Aldrich and used as received. 
1
H 
NMR spectra were recorded on Avance III 400SL (400 MHz) or Avance III 500 Ascend 
(500 MHz) spectrometers. 
1H NMR chemical shifts (δ) are reported in parts per million 
(ppm) relative to tetramethylsilane internal standard (0 ppm) or DMSO-d internal standard 
(2.50 ppm). Data are reported as follows: (s = singlet, br s = broad singlet, d = doublet, br d 
=broad doublet, t = triplet, q = quartet, quint = quintet, dd = doublet of doublets, dq = 
doublet of quartets, ddd = doublet of doublet of doublets, ddt = doublet of doublet of 
triplets, m = multiplet; integration; coupling constant in Hz; assignment). Proton decoupled 
13
C NMR spectra were recorded on Avance III 400SL (100 MHz) or Avance III 500 
Ascend (125 MHz) or Bruker DPX-300 (75 MHz) spectrometers and are reported in ppm 
from CDCl3 internal standard (77.16 ppm) or DMSO-d internal standard (39.52 ppm). 







Preparation of Silane 4.12 
 In a flame-fried 500 mL reound bottom flask, dissolved allyltrichlorosilane (14 mL, 
96.6 mmol) in CH2Cl2 (220 mL). The solution was stirred and cooled to 0°C and added 
DBU (28 mL, 187 mmol) slowly. Pinacol (11 g, 92.8 mmol) was then slowly added at 0°C 
as a solution in CH2Cl2 (30 mL) via addition funnel. The ice bath was allowed to expire to 
room temperature overnight (or in about 2-3 hours – check 1H NMR). The resulting pale 
yellow solution was cooled to 0°C and added DBU (14 mL, 93.6 mmol), followed by 
anhydrous methanol (4 mL, 98.6 mmol). The reaction can be left overnight to reach room 
temperature or stopped after completion in about 2-3 hours (check 
1
H NMR). The solvent 
was concentrated under vacuum and the residue was triturated with diethyl ether. Vigorous 
stirring is required as the DBU salts tend to glue to the bottom of the flask. After the salts 
were nicely suspended and freely stirring in the flask, the mixture was filtered using an air-
free frit. The filtrate was evaporated under vacuum, and the residue was purified by vacuum 
distillation (40°C, 0.2-0.5 mm Hg) to give a colorless clear oil (14.8 g, 74% yield). 
1
H NMR 
(300 MHz, CDCl3) δ 5.80 (ddt, J = 17.7, 10.0, 7.8 Hz, 1H), 5.13 – 4.83 (m, 2H), 3.58 (s, 
3H), 1.73 (dt, J = 7.7, 1.4 Hz, 2H), 1.25 (d, J = 12.8 Hz, 12H). 
13
C NMR (75 MHz, CDCl3) 
δ 131.78, 115.42, 81.27, 51.16, 25.81, 25.75, 19.09. 29Si NMR (60 MHz, CDCl3) δ -30.54. 









General Procedure for the Catalytic Asymmetric Allylation of Aldehydes (Table 4-6): 
 A Fisherbrand
®
 disposable culture tube (borosilicate glass, 13 x 100 mL) was 
equipped with a stir bar, flame-dried under vacuum, and backfilled with dry nitrogen gas 
once at room temperature. The tube above was charged with bismuth triflate (14 mg, 10 
mol%) and (S,R)-IndaPyBOX (13 mg, 15 mol%), followed by anhydrous dichloromethane 
or DCE at room temperature. The contents were well mixed for 30 minutes
1
.  The starting 
heterogeneous mixture became homogeneous in the first 5-10 minutes. Silane 4.12 (0.226 
mmol) was then added to the above mixture at room temperature and stirred for additional 
10 minutes. A yellow coloring was observed a few minutes later. Finally, the aldehyde was 
added at room temperature and allowed to stir for 48 hours. The reaction was cooled to 0°C 
and quenched with TBAF (0.45 mL, 2 equiv., 1.0M in THF) and allowed to reach room 
temperature while stirring. Solvents were evaporated under vacuum, and the reaction crude 
was purified via silica gel chromatography (solvent gradient: 100% to 80% hexanes/ethyl 
acetate). The resulting products in Table 4-6 have been previously synthesized and 
characterized before in our group, so absolute stereochemistry was obtained by comparing 
with originally reported HPLC traces
2
. 
Modified Procedure for the Catalytic Asymmetric Allylation of Aldehydes (high ee): 
The reaction vessel (3-dram vial or base bathed round bottom flask) was equipped with a 
stir bar, flame-dried under vacuum, and backfilled with dry nitrogen gas once at room 
temperature. The tube above was charged with bismuth triflate (14 mg, 10 mol%), (S,R)-
                                                          
1
  According by 
1
H NMR of a 1:1 mixture of Bi(OTf)3 and IndaPyBOX, there are  no observable changes in 
chemical shifts after 10 minutes. Originally, reactions were run after thirty minutes of complexation. 
 
2
  Kinnaird, J. W. A.; Ng, P. Y.; Kubota, K.; Wang, X.; Leighton, J. L. Journal of the American Chemical 





IndaPyBOX (13 mg, 15 mol%), and 2,6-ditert-butyl-4-methyl pyridine (10 mg, 5 mol%), 
followed by anhydrous dichloromethane or DCE at room temperature. The contents were 
well mixed for 30 minutes.  Silane 4.12 (0.226 mmol) was then added to the above mixture 
at room temperature and stirred for additional 10 minutes, followed by addition of the 
aldehyde at room temperature and allowed to stir for 48 hours (for ee measurement 
purposes, reaction takes longer time for completion). The reaction was cooled to 0°C and 
quenched with TBAF (0.45 mL, 2 equiv., 1.0M in THF) and allowed to reach room 
temperature while stirring. Solvents were evaporated under vacuum, and the reaction crude 



















I. NMR Spectra 
 
      
 
       





   
   
 
























































































































































II. HPLC Traces 
Chiracel OJ-H, 85:15 hexane/isopropanol, 1.0 ml/min, 254 nm: 
 
 
   
 














Chiracel AD-H, 90:10  hexane/ethanol, 1.0 ml/min, 254 nm: 
 






Chiracel OJ-H, 90:10 hexane/isopropanol, 1.0 ml/min, 254 nm: 


























Chiralpak AD-H 98:2 Hex/IPA, 1.0 mL/min, 230 nm 
 
 

































Chiralpak AD-H 95:5 Hex/IPA, 1.0 mL/min, 230 nm 
 
 





















































Chiralcel OD 95:5 Hex/IPA, 1.0 mL/min, 220 nm 
 
 
 
 
 
 
